| Year |
Citation |
Score |
| 2023 |
Hirschberg Y, Valle-Tamayo N, Dols-Icardo O, Engelborghs S, Buelens B, Vandenbroucke RE, Vermeiren Y, Boonen K, Mertens I. Proteomic comparison between non-purified cerebrospinal fluid and cerebrospinal fluid-derived extracellular vesicles from patients with Alzheimer's, Parkinson's and Lewy body dementia. Journal of Extracellular Vesicles. 12: e12383. PMID 38082559 DOI: 10.1002/jev2.12383 |
0.374 |
|
| 2023 |
Bosmans J, Gommeren H, Zu Eulenburg P, Gilles A, Mertens G, Van Ombergen A, Cras P, Engelborghs S, Van Rompaey V. Is vestibular function related to human hippocampal volume? Journal of Vestibular Research : Equilibrium & Orientation. PMID 37927291 DOI: 10.3233/VES-230076 |
0.3 |
|
| 2023 |
Richter AL, Diepeveen-de Bruin M, Balvers MGJ, De Groot LCPGM, De Deyn PP, Engelborghs S, Witkamp RF, Vermeiren Y. Association between low vitamin D status, serotonin and clinico-bio-behavioral parameters in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. PMID 37806302 DOI: 10.1159/000534492 |
0.317 |
|
| 2023 |
Neumann A, Ohlei O, Küçükali F, Bos IJ, Timsina J, Vos S, Prokopenko D, Tijms BM, Andreasson U, Blennow K, Vandenberghe R, Scheltens P, Teunissen CE, Engelborghs S, Frisoni GB, et al. Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning. Genome Medicine. 15: 79. PMID 37794492 DOI: 10.1186/s13073-023-01233-z |
0.335 |
|
| 2023 |
Del Campo M, Vermunt L, Peeters CFW, Sieben A, Hok-A-Hin YS, Lleó A, Alcolea D, van Nee M, Engelborghs S, van Alphen JL, Arezoumandan S, Chen-Plotkin A, Irwin DJ, van der Flier WM, Lemstra AW, et al. CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease. Nature Communications. 14: 5635. PMID 37704597 DOI: 10.1038/s41467-023-41122-y |
0.362 |
|
| 2023 |
Bosmans J, Gommeren H, Gilles A, Mertens G, Van Ombergen A, Cras P, Engelborghs S, Vereeck L, Lammers MJW, Van Rompaey V. Evidence of Vestibular and Balance Dysfunction in Patients With Mild Cognitive Impairment and Alzheimer's Disease. Ear and Hearing. PMID 37482637 DOI: 10.1097/AUD.0000000000001401 |
0.396 |
|
| 2023 |
Shi L, Xu J, Green R, Wretlind A, Homann J, Buckley NJ, Tijms BM, Vos SJB, Lill CM, Kate MT, Engelborghs S, Sleegers K, Frisoni GB, Wallin A, Lleó A, et al. Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36790009 DOI: 10.1002/alz.12961 |
0.397 |
|
| 2022 |
Küçükali F, Neumann A, Van Dongen J, De Pooter T, Joris G, De Rijk P, Ohlei O, Dobricic V, Bos I, Vos SJB, Engelborghs S, De Roeck E, Vandenberghe R, Gabel S, Meersmans K, et al. Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36464806 DOI: 10.1002/alz.12842 |
0.35 |
|
| 2022 |
Laton J, Van Schependom J, Goossens J, Wiels W, Sieben A, De Deyn PP, Goeman J, Streffer J, van der Zee J, Martin JJ, Van Broeckhoven C, De Vos M, Bjerke M, Nagels G, Engelborghs S. Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study. Journal of Alzheimer's Disease : Jad. 90: 1739-1747. PMID 36336933 DOI: 10.3233/JAD-220693 |
0.377 |
|
| 2022 |
Gossye H, Van Mossevelde S, Sieben A, Bjerke M, Van de Craen EH, van der Zee J, De Deyn PP, De Bleecker J, Versijpt J, van den Ende J, Deryck O, Bourgeois P, Bier JC, Goethals M, Vandenberghe R, ... Engelborghs S, et al. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum. Brain : a Journal of Neurology. PMID 36171642 DOI: 10.1093/brain/awac362 |
0.429 |
|
| 2022 |
Jansen IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, Dalmasso MC, Grenier-Boley B, Zettergren A, Mishra A, Ali M, Andrade V, Bellenguez C, Kleineidam L, Küçükali F, Sung YJ, Tesí N, ... ... Engelborghs S, et al. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers. Acta Neuropathologica. PMID 36066633 DOI: 10.1007/s00401-022-02454-z |
0.374 |
|
| 2022 |
Meulemans C, Leijten M, Van Waes L, Engelborghs S, De Maeyer S. Cognitive Writing Process Characteristics in Alzheimer's Disease. Frontiers in Psychology. 13: 872280. PMID 35899013 DOI: 10.3389/fpsyg.2022.872280 |
0.311 |
|
| 2022 |
Vromen EM, de Boer SCM, Teunissen CE, Rozemuller A, Sieben A, Bjerke M, Visser PJ, Bouwman FH, Engelborghs S, Tijms BM. Biomarker A+T-: is this Alzheimer's disease or not? A combined CSF and pathology study. Brain : a Journal of Neurology. PMID 35511164 DOI: 10.1093/brain/awac158 |
0.392 |
|
| 2022 |
Bouwman FH, Frisoni GB, Johnson SC, Chen X, Engelborghs S, Ikeuchi T, Paquet C, Ritchie C, Bozeat S, Quevenco FC, Teunissen C. Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12314. PMID 35496374 DOI: 10.1002/dad2.12314 |
0.407 |
|
| 2022 |
Homann J, Osburg T, Ohlei O, Dobricic V, Deecke L, Bos I, Vandenberghe R, Gabel S, Scheltens P, Teunissen CE, Engelborghs S, Frisoni G, Blin O, Richardson JC, Bordet R, et al. Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery Dataset. Frontiers in Aging Neuroscience. 14: 840651. PMID 35386118 DOI: 10.3389/fnagi.2022.840651 |
0.338 |
|
| 2022 |
Bellenguez C, Küçükali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, Naj AC, Campos-Martin R, Grenier-Boley B, Andrade V, Holmans PA, Boland A, Damotte V, van der Lee SJ, Costa MR, ... ... Engelborghs S, et al. New insights into the genetic etiology of Alzheimer's disease and related dementias. Nature Genetics. PMID 35379992 DOI: 10.1038/s41588-022-01024-z |
0.378 |
|
| 2022 |
Visser PJ, Reus LM, Gobom J, Jansen I, Dicks E, van der Lee SJ, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuevo JL, Engelborghs S, Freund-Levi Y, et al. Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease. Molecular Neurodegeneration. 17: 27. PMID 35346299 DOI: 10.1186/s13024-022-00521-3 |
0.313 |
|
| 2022 |
Bridel C, Somers C, Sieben A, Rozemuller A, Niemantsverdriet E, Struyfs H, Vermeiren Y, Van Broeckhoven C, De Deyn PP, Bjerke M, Nagels G, Teunissen CE, Engelborghs S. Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers. Brain : a Journal of Neurology. PMID 35026840 DOI: 10.1093/brain/awac013 |
0.383 |
|
| 2021 |
Delaby C, Teunissen CE, Blennow K, Alcolea D, Arisi I, Amar EB, Beaume A, Bedel A, Bellomo G, Bigot-Corbel E, Bjerke M, Blanc-Quintin MC, Boada M, Bousiges O, Chapman MD, ... ... Engelborghs S, et al. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34936194 DOI: 10.1002/alz.12545 |
0.34 |
|
| 2021 |
Gommeren H, Bosmans J, Cardon E, Mertens G, Cras P, Engelborghs S, Van Ombergen A, Gilles A, Lammers M, Van Rompaey V. Cortical Auditory Evoked Potentials in Cognitive Impairment and Their Relevance to Hearing Loss: A Systematic Review Highlighting the Evidence Gap. Frontiers in Neuroscience. 15: 781322. PMID 34867176 DOI: 10.3389/fnins.2021.781322 |
0.301 |
|
| 2021 |
Xu J, Green R, Kim M, Lord J, Ebshiana A, Westwood S, Baird AL, Nevado-Holgado AJ, Shi L, Hye A, Snowden SG, Bos I, Vos SJB, Vandenberghe R, Teunissen CE, ... ... Engelborghs S, et al. Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort. Biomedicines. 9. PMID 34829839 DOI: 10.3390/biomedicines9111610 |
0.31 |
|
| 2021 |
Willemse EAJ, Sieben A, Somers C, Vermeiren Y, De Roeck N, Timmers M, Van Broeckhoven C, De Vil B, Cras P, De Deyn PP, Martin JJ, Teunissen CE, Engelborghs S, Bjerke M. Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia. Neurobiology of Aging. 108: 99-109. PMID 34551375 DOI: 10.1016/j.neurobiolaging.2021.08.002 |
0.348 |
|
| 2021 |
Wiels WA, Wittens MMJ, Zeeuws D, Baeken C, Engelborghs S. Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits. Frontiers in Psychiatry. 12: 707580. PMID 34483998 DOI: 10.3389/fpsyt.2021.707580 |
0.427 |
|
| 2021 |
Tijms BM, Gobom J, Teunissen C, Dobricic V, Tsolaki M, Verhey F, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, Molinuévo JL, Engelborghs S, Freund-Levi Y, Froelich L, Bertram L, et al. CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals. Proteomes. 9. PMID 34449748 DOI: 10.3390/proteomes9030036 |
0.37 |
|
| 2021 |
Shi L, Buckley NJ, Bos I, Engelborghs S, Sleegers K, Frisoni GB, Wallin A, Lléo A, Popp J, Martinez-Lage P, Legido-Quigley C, Barkhof F, Zetterberg H, Visser PJ, Bertram L, et al. Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies. Frontiers in Aging Neuroscience. 13: 712545. PMID 34366831 DOI: 10.3389/fnagi.2021.712545 |
0.38 |
|
| 2021 |
Nous A, Wittens MMJ, Vermeiren Y, De Deyn PP, Van Broeckhoven C, Nagels G, Smolders I, Engelborghs S. Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer's Disease but Are Not Correlated with Cognitive Decline. Journal of Alzheimer's Disease : Jad. PMID 34366353 DOI: 10.3233/JAD-210562 |
0.334 |
|
| 2021 |
Wittens MMJ, Sima DM, Houbrechts R, Ribbens A, Niemantsverdriet E, Fransen E, Bastin C, Benoit F, Bergmans B, Bier JC, De Deyn PP, Deryck O, Hanseeuw B, Ivanoiu A, Lemper JC, ... ... Engelborghs S, et al. Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER Study. Journal of Alzheimer's Disease : Jad. PMID 34334402 DOI: 10.3233/JAD-210450 |
0.366 |
|
| 2021 |
Hong S, Dobricic V, Ohlei O, Bos I, Vos SJB, Prokopenko D, Tijms BM, Andreasson U, Blennow K, Vandenberghe R, Gabel S, Scheltens P, Teunissen CE, Engelborghs S, Frisoni G, et al. TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33991015 DOI: 10.1002/alz.12330 |
0.303 |
|
| 2021 |
Bosmans J, Jorissen C, Gilles A, Mertens G, Engelborghs S, Cras P, Van Ombergen A, Van Rompaey V. Vestibular Function in Older Adults With Cognitive Impairment: A Systematic Review. Ear and Hearing. PMID 33974775 DOI: 10.1097/AUD.0000000000001040 |
0.403 |
|
| 2021 |
Shi L, Winchester LM, Westwood S, Baird AL, Anand SN, Buckley NJ, Hye A, Ashton NJ, Bos I, Vos SJB, Kate MT, Scheltens P, Teunissen CE, Vandenberghe R, Gabel S, ... ... Engelborghs S, et al. Replication study of plasma proteins relating to Alzheimer's pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33792144 DOI: 10.1002/alz.12322 |
0.336 |
|
| 2021 |
Sieben A, Van Langenhove T, Vermeiren Y, Gossye H, Praet M, Vanhauwaert D, Cousaert C, Engelborghs S, Raedt R, Boon P, Santens P, De Deyn PP, Bracke KR, De Meulemeester K, Van Broeckhoven C, et al. Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration. Journal of Neuropathology and Experimental Neurology. PMID 33638350 DOI: 10.1093/jnen/nlab010 |
0.319 |
|
| 2021 |
Nous A, Engelborghs S, Smolders I. Melatonin levels in the Alzheimer's disease continuum: a systematic review. Alzheimer's Research & Therapy. 13: 52. PMID 33622399 DOI: 10.1186/s13195-021-00788-6 |
0.302 |
|
| 2020 |
Tijms BM, Gobom J, Reus L, Jansen I, Hong S, Dobricic V, Kilpert F, Ten Kate M, Barkhof F, Tsolaki M, Verhey FRJ, Popp J, Martinez-Lage P, Vandenberghe R, Lleó A, ... ... Engelborghs S, et al. Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics. Brain : a Journal of Neurology. 143: 3776-3792. PMID 33439986 DOI: 10.1093/brain/awaa325 |
0.413 |
|
| 2020 |
Frederiksen KS, Nielsen TR, Winblad B, Schmidt R, Kramberger MG, Jones RW, Hort J, Grimmer T, Georges J, Frölich L, Engelborghs S, Dubois B, Waldemar G. European Academy of Neurology/European Alzheimer's Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment. European Journal of Neurology. PMID 33368924 DOI: 10.1111/ene.14668 |
0.329 |
|
| 2020 |
Hong S, Prokopenko D, Dobricic V, Kilpert F, Bos I, Vos SJB, Tijms BM, Andreasson U, Blennow K, Vandenberghe R, Cleynen I, Gabel S, Schaeverbeke J, Scheltens P, Teunissen CE, ... ... Engelborghs S, et al. Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset. Translational Psychiatry. 10: 403. PMID 33223526 DOI: 10.1038/s41398-020-01074-z |
0.358 |
|
| 2020 |
Bosmans J, Jorissen C, Cras P, Van Ombergen A, Engelborghs S, Gilles A, Princen E, Moyaert J, Mertens G, Van Rompaey V. Impact of hearing loss and vestibular decline on cognition in Alzheimer's disease: a prospective longitudinal study protocol (Gehoor, Evenwicht en Cognitie, GECkO). Bmj Open. 10: e039601. PMID 32948575 DOI: 10.1136/Bmjopen-2020-039601 |
0.464 |
|
| 2020 |
Bosmans J, Jorissen C, Cras P, Van Ombergen A, Engelborghs S, Gilles A, Princen E, Moyaert J, Mertens G, Van Rompaey V. Impact of hearing loss and vestibular decline on cognition in Alzheimer's disease: a prospective longitudinal study protocol (Gehoor, Evenwicht en Cognitie, GECkO). Bmj Open. 10: e039601. PMID 32948575 DOI: 10.1136/bmjopen-2020-039601 |
0.359 |
|
| 2020 |
Ivanoiu A, Engelborghs S, Hanseeuw B. [Early diagnosis of Alzheimer's disease (with the announcement of the diagnosis)]. La Revue Du Praticien. 70: 158-163. PMID 32877127 |
0.32 |
|
| 2020 |
Shi L, Winchester LM, Liu BY, Killick R, Ribe EM, Westwood S, Baird AL, Buckley NJ, Hong S, Dobricic V, Kilpert F, Franke A, Kiddle S, Sattlecker M, Dobson R, ... ... Engelborghs S, et al. Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology. Journal of Alzheimer's Disease : Jad. PMID 32831200 DOI: 10.3233/Jad-200208 |
0.423 |
|
| 2020 |
Saddiki H, Fayosse A, Cognat E, Sabia S, Engelborghs S, Wallon D, Alexopoulos P, Blennow K, Zetterberg H, Parnetti L, Zerr I, Hermann P, Gabelle A, Boada M, Orellana A, et al. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study. Plos Medicine. 17: e1003289. PMID 32817639 DOI: 10.1371/journal.pmed.1003289 |
0.372 |
|
| 2020 |
Mormont E, Bier JC, Bruffaerts R, Cras P, De Deyn P, Deryck O, Engelborghs S, Petrovic M, Picard G, Segers K, Thiery E, Versijpt J, Hanseeuw B. Practices and opinions about disclosure of the diagnosis of Alzheimer's disease to patients with MCI or dementia: a survey among Belgian medical experts in the field of dementia. Acta Neurologica Belgica. PMID 32715405 DOI: 10.1007/S13760-020-01448-6 |
0.412 |
|
| 2020 |
Novak G, Streffer JR, Timmers M, Henley D, Brashear HR, Bogert J, Russu A, Janssens L, Tesseur I, Tritsmans L, Van Nueten L, Engelborghs S. Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study. Alzheimer's Research & Therapy. 12: 58. PMID 32410694 DOI: 10.1186/s13195-020-00614-5 |
0.316 |
|
| 2020 |
Verelst J, Geukens N, Eddarkaoui S, Vliegen D, De Smidt E, Rosseels J, Franssens V, Molenberghs S, Francois C, Stoops E, Bjerke M, Engelborghs S, Laghmouchi M, Carmans S, Buée L, et al. A Novel Tau Antibody Detecting the First Amino-Terminal Insert Reveals Conformational Differences Among Tau Isoforms. Frontiers in Molecular Biosciences. 7: 48. PMID 32296712 DOI: 10.3389/Fmolb.2020.00048 |
0.308 |
|
| 2020 |
Van Rickstal R, De Vleminck A, Morrison SR, Koopmans RT, van der Steen JT, Engelborghs S, Neugroschl J, Aldridge MD, Sano M, Van den Block L. Comparing Advance Care Planning in Young-Onset Dementia in the USA vs Belgium: Challenges Partly Related to Societal Context. Journal of the American Medical Directors Association. PMID 32173310 DOI: 10.1016/J.Jamda.2020.01.007 |
0.353 |
|
| 2020 |
Westwood S, Baird AL, Anand SN, Nevado-Holgado AJ, Kormilitzin A, Shi L, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Baker S, Buckley NJ, Ten Kate M, Scheltens P, ... ... Engelborghs S, et al. Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort. Journal of Alzheimer's Disease : Jad. PMID 31985466 DOI: 10.3233/Jad-190434 |
0.35 |
|
| 2019 |
Stamate D, Kim M, Proitsi P, Westwood S, Baird A, Nevado-Holgado A, Hye A, Bos I, Vos SJB, Vandenberghe R, Teunissen CE, Kate MT, Scheltens P, Gabel S, Meersmans K, ... ... Engelborghs S, et al. A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort. Alzheimer's & Dementia (New York, N. Y.). 5: 933-938. PMID 31890857 DOI: 10.1016/J.Trci.2019.11.001 |
0.303 |
|
| 2019 |
Shi L, Westwood S, Baird AL, Winchester L, Dobricic V, Kilpert F, Hong S, Franke A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Buckley NJ, Kate MT, ... ... Engelborghs S, et al. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31495601 DOI: 10.1016/J.Jalz.2019.06.4951 |
0.339 |
|
| 2019 |
Gossye H, Van Broeckhoven C, Engelborghs S. The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications. Frontiers in Neuroscience. 13: 757. PMID 31447625 DOI: 10.3389/fnins.2019.00757 |
0.38 |
|
| 2019 |
De Roeck EE, van der Vorst A, Engelborghs S, Zijlstra GAR, Dierckx E. Exploring Cognitive Frailty: Prevalence and Associations with Other Frailty Domains in Older People with Different Degrees of Cognitive Impairment. Gerontology. 1-10. PMID 31330515 DOI: 10.1159/000501168 |
0.339 |
|
| 2019 |
Picard G, Bier JC, Capron I, De Deyn PP, Deryck O, Engelborghs S, Hanseeuw B, Lemper JC, Mormont E, Petrovic M, Salmon E, Segers K, Sieben A, Thiery E, Ventura M, et al. Dementia, End of Life, and Euthanasia: A Survey Among Dementia Specialists Organized by the Belgian Dementia Council. Journal of Alzheimer's Disease : Jad. PMID 31127774 DOI: 10.3233/JAD-181277 |
0.317 |
|
| 2019 |
Kim M, Snowden S, Suvitaival T, Ali A, Merkler DJ, Ahmad T, Westwood S, Baird A, Proitsi P, Nevado-Holgado A, Hye A, Bos I, Vos S, Vandenberghe R, Teunissen C, ... ... Engelborghs S, et al. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31078433 DOI: 10.1016/J.Jalz.2019.03.004 |
0.463 |
|
| 2019 |
Timmers M, Tesseur I, Bogert J, Zetterberg H, Blennow K, Börjesson-Hanson A, Baquero M, Boada M, Randolph C, Tritsmans L, Van Nueten L, Engelborghs S, Streffer JR. Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease. Neurobiology of Aging. 79: 131-141. PMID 31055223 DOI: 10.1016/j.neurobiolaging.2019.03.016 |
0.394 |
|
| 2019 |
Morgan AR, Touchard S, Leckey C, O'Hagan C, Nevado-Holgado AJ, Barkhof F, Bertram L, Blin O, Bos I, Dobricic V, Engelborghs S, Frisoni G, Frölich L, Gabel S, et al. Inflammatory biomarkers in Alzheimer's disease plasma. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31047856 DOI: 10.1016/J.Jalz.2019.03.007 |
0.414 |
|
| 2019 |
Ottoy J, Niemantsverdriet E, Verhaeghe J, De Roeck E, Struyfs H, Somers C, Wyffels L, Ceyssens S, Van Mossevelde S, Van den Bossche T, Van Broeckhoven C, Ribbens A, Bjerke M, Stroobants S, Engelborghs S, et al. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and F-FDG-PET imaging. Neuroimage. Clinical. 22: 101771. PMID 30927601 DOI: 10.1016/J.Nicl.2019.101771 |
0.486 |
|
| 2019 |
Somers C, Lewczuk P, Sieben A, Van Broeckhoven C, De Deyn PP, Kornhuber J, Martin JJ, Bjerke M, Engelborghs S. Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects. Journal of Alzheimer's Disease : Jad. PMID 30883344 DOI: 10.3233/Jad-180563 |
0.401 |
|
| 2019 |
Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, et al. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30853464 DOI: 10.1016/J.Jalz.2019.01.004 |
0.437 |
|
| 2019 |
Cacace R, Vos KD, Heeman B, Mossevelde SV, Sieben A, Engelborghs S, Deyn PPD, Martin J, Broeckhoven CV. P1-210: Investigating The Involvement Of The Dpp6-Kv4.2 Protein Complex In Dementia Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.765 |
0.358 |
|
| 2018 |
Ten Kate M, Redolfi A, Peira E, Bos I, Vos SJ, Vandenberghe R, Gabel S, Schaeverbeke J, Scheltens P, Blin O, Richardson JC, Bordet R, Wallin A, Eckerstrom C, Molinuevo JL, ... Engelborghs S, et al. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study. Alzheimer's Research & Therapy. 10: 100. PMID 30261928 DOI: 10.1186/S13195-018-0428-1 |
0.474 |
|
| 2018 |
Timmers M, Streffer JR, Russu A, Tominaga Y, Shimizu H, Shiraishi A, Tatikola K, Smekens P, Börjesson-Hanson A, Andreasen N, Matias-Guiu J, Baquero M, Boada M, Tesseur I, Tritsmans L, ... ... Engelborghs S, et al. Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study. Alzheimer's Research & Therapy. 10: 85. PMID 30134967 DOI: 10.1186/S13195-018-0415-6 |
0.441 |
|
| 2018 |
Van Schependom J, Niemantsverdriet E, Smeets D, Engelborghs S. Callosal circularity as an early marker for Alzheimer's disease. Neuroimage. Clinical. 19: 516-526. PMID 29984160 DOI: 10.1016/J.Nicl.2018.05.018 |
0.435 |
|
| 2018 |
Bos I, Vos S, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni G, Molinuevo JL, Wallin A, Lleó A, Popp J, Martinez-Lage P, Baird A, Dobson R, Legido-Quigley C, Sleegers K, et al. The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. Alzheimer's Research & Therapy. 10: 64. PMID 29980228 DOI: 10.1186/S13195-018-0396-5 |
0.447 |
|
| 2018 |
Perrone F, Cacace R, Van Mossevelde S, Van den Bossche T, De Deyn PP, Cras P, Engelborghs S, van der Zee J, Van Broeckhoven C. Genetic screening in early-onset dementia patients with unclear phenotype: relevance for clinical diagnosis. Neurobiology of Aging. PMID 29859640 DOI: 10.1016/J.Neurobiolaging.2018.04.015 |
0.434 |
|
| 2018 |
Van Mossevelde S, Engelborghs S, van der Zee J, Van Broeckhoven C. Genotype-phenotype links in frontotemporal lobar degeneration. Nature Reviews. Neurology. PMID 29777184 DOI: 10.1038/S41582-018-0009-8 |
0.329 |
|
| 2018 |
De Roeck EE, Dury S, De Witte N, De Donder L, Bjerke M, De Deyn PP, Engelborghs S, Dierckx E. CFAI-Plus: Adding cognitive frailty as a new domain to the comprehensive frailty assessment instrument. International Journal of Geriatric Psychiatry. PMID 29637620 DOI: 10.1002/Gps.4875 |
0.377 |
|
| 2018 |
Niemantsverdriet E, Feyen BFE, Le Bastard N, Martin JJ, Goeman J, De Deyn PP, Bjerke M, Engelborghs S. Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort. Journal of Alzheimer's Disease : Jad. PMID 29614653 DOI: 10.3233/Jad-170927 |
0.43 |
|
| 2018 |
Mattsson N, Groot C, Jansen WJ, Landau S, Villemagne V, Engelborghs S, Mintun M, Lleo A, Molinuevo JL, Jagust W, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29601787 DOI: 10.1016/J.Jalz.2018.02.009 |
0.321 |
|
| 2018 |
De Roeck A, Duchateau L, Van Dongen J, Cacace R, Bjerke M, Van den Bossche T, Cras P, Vandenberghe R, De Deyn PP, Engelborghs S, Van Broeckhoven C, Sleegers K. An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer's disease. Acta Neuropathologica. PMID 29589097 DOI: 10.1007/S00401-018-1841-Z |
0.425 |
|
| 2018 |
Bjerke M, Engelborghs S. Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis. Journal of Alzheimer's Disease : Jad. 62: 1199-1209. PMID 29562530 DOI: 10.3233/Jad-170680 |
0.471 |
|
| 2018 |
Goossens J, Bjerke M, Van Mossevelde S, Van den Bossche T, Goeman J, De Vil B, Sieben A, Martin JJ, Cras P, De Deyn PP, Van Broeckhoven C, van der Zee J, Engelborghs S. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. Alzheimer's Research & Therapy. 10: 31. PMID 29559004 DOI: 10.1186/S13195-018-0364-0 |
0.449 |
|
| 2018 |
Janssens J, Vermeiren Y, Fransen E, Aerts T, Van Dam D, Engelborghs S, De Deyn PP. Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 172-181. PMID 29552632 DOI: 10.1016/J.Dadm.2018.01.002 |
0.51 |
|
| 2018 |
Teunissen CE, Otto M, Engelborghs S, Herukka SK, Lehmann S, Lewczuk P, Lleó A, Perret-Liaudet A, Tumani H, Turner MR, Verbeek MM, Wiltfang J, Zetterberg H, Parnetti L, Blennow K. White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation. Alzheimer's Research & Therapy. 10: 30. PMID 29544527 DOI: 10.1186/S13195-018-0359-X |
0.336 |
|
| 2018 |
Willemse EAJ, De Vos A, Herries EM, Andreasson U, Engelborghs S, van der Flier WM, Scheltens P, Crimmins D, Ladenson JH, Vanmechelen E, Zetterberg H, Fagan AM, Blennow K, Bjerke M, Teunissen CE. Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study. Clinical Chemistry. PMID 29523639 DOI: 10.1373/Clinchem.2017.283028 |
0.494 |
|
| 2018 |
Vloeberghs R, Opmeer EM, De Deyn PP, Engelborghs S, De Roeck EE. [Apathy, depression and cognitive functioning in patients with MCI and dementia]. Tijdschrift Voor Gerontologie En Geriatrie. PMID 29488192 DOI: 10.1007/S12439-018-0248-6 |
0.39 |
|
| 2018 |
Willemse EAJ, Sieben A, Somers C, Vermeiren Y, Roeck ND, Luyckx J, Broeckhoven CV, Vil BD, Cras P, Deyn PPD, Martin J, Teunissen CE, Engelborghs S, Bjerke M. P4-270: Neurogranin In Cerebrospinal Fluid Is Not Specific To Alzheimer'S Disease Dementia Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.07.092 |
0.494 |
|
| 2018 |
Willemse EAJ, Vermeiren Y, García-Ayllón M, Bridel C, Deyn PPD, Engelborghs S, Flier WMVd, Janssen E, Font IL, Manadas B, Mendes VM, Roeck ND, Sáez-Valero J, Struys EA, Uffelen KWv, et al. P2-228: Pre-Analytical Stability Of Novel Cerebrospinal Fluid Biomarkers For Dementia Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.915 |
0.388 |
|
| 2018 |
Roeck AD, Duchateau L, Dongen JV, Cacace R, Bjerke M, Bossche TVd, Cras P, Vandenberghe R, Deyn PPD, Engelborghs S, Broeckhoven CV, Sleegers K. O4-01-01: In-Depth Analysis Of An Abca7 Vntr In Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2909 |
0.373 |
|
| 2018 |
Hong S, Dobricic V, Smith RG, Küçükali F, Kilpert F, Bos I, Vos SJB, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni GB, Blin O, Richardson J, Bordet R, Tsolaki M, et al. F1-02-04: Genomics And Epigenomics Analyses In The Emif-Ad Multimodal Biomarker Discovery Study Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2310 |
0.322 |
|
| 2018 |
Bos I, Vos SJB, Verhey FRJ, Scheltens P, Engelborghs S, Frisoni GB, Blin O, Richardson J, Bordet R, Tsolaki M, Popp J, Martinez-Lage P, Lleó A, Johannsen P, Freund-Levi Y, et al. F1-02-01: RELATING CSF MARKERS NEUROGRANIN, NEUROFILAMENT-LIGHT AND YKL-40 TO Aβ, APOE ε4 AND COGNITION: RESULTS FROM THE EMIF-AD MULTIMODAL BIOMARKER DISCOVERY STUDY Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2307 |
0.431 |
|
| 2018 |
Kim M, Snowden SG, Ahmad T, Westwood S, Baird AL, Proitsi P, Nevado-Holgado AJ, Hye A, Ashton NJ, Bos I, Vos SJB, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni GB, et al. P3-233: PLASMA PRIMARY FATTY AMIDES ASSOCIATE TO CSF AMYLOID LEVELS AND ALZHEIMER\textquotesingleS DISEASE PROGRESSION IN THE EMIF-AD BIOMARKER DISCOVERY COHORT Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1592 |
0.456 |
|
| 2018 |
Cacace R, Hoogmartens J, Mossevelde SV, Bossche TVd, Geerts N, Vandenberghe R, Deyn PPD, Zee Jvd, Engelborghs S, Sleegers K, Broeckhoven CV. P3-128: Exploring The Molecular Mechanism Of Neuronal Hyperexcitability In Dementia Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1485 |
0.324 |
|
| 2017 |
Ottoy J, Verhaeghe J, Niemantsverdriet E, Engelborghs S, Stroobants S, Staelens S. A simulation study on the impact of the blood flow-dependent component in [18F]AV45 SUVR in Alzheimer's disease. Plos One. 12: e0189155. PMID 29211812 DOI: 10.1371/Journal.Pone.0189155 |
0.355 |
|
| 2017 |
Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/Jamapsychiatry.2017.3391 |
0.466 |
|
| 2017 |
Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR, Teunissen CE, Hampel H, Lleó A, Jessen F, et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-85. PMID 29076399 DOI: 10.1080/15622975.2017.1375556 |
0.319 |
|
| 2017 |
Versijpt J, Tant M, Beyer I, Bier JC, Cras P, De Deyn PP, De Wit P, Deryck O, Hanseeuw B, Lambert M, Lemper JC, Mormont E, Petrovic M, Picard G, Salmon E, ... ... Engelborghs S, et al. Alzheimer's disease and driving: review of the literature and consensus guideline from Belgian dementia experts and the Belgian road safety institute endorsed by the Belgian Medical Association. Acta Neurologica Belgica. PMID 28983881 DOI: 10.1007/S13760-017-0840-5 |
0.354 |
|
| 2017 |
Niemantsverdriet E, Ottoy J, Somers C, De Roeck E, Struyfs H, Soetewey F, Verhaeghe J, Van den Bossche T, Van Mossevelde S, Goeman J, De Deyn PP, Mariën P, Versijpt J, Sleegers K, Van Broeckhoven C, ... ... Engelborghs S, et al. The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting. Journal of Alzheimer's Disease : Jad. PMID 28869470 DOI: 10.3233/Jad-170327 |
0.411 |
|
| 2017 |
Niemantsverdriet E, Valckx S, Bjerke M, Engelborghs S. Alzheimer's disease CSF biomarkers: clinical indications and rational use. Acta Neurologica Belgica. PMID 28752420 DOI: 10.1007/S13760-017-0816-5 |
0.496 |
|
| 2017 |
Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S, De Roeck N, Tambasco N, Stoops E, Vanderstichele H, Engelborghs S, Mollenhauer B, Calabresi P, Parnetti L. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia. Alzheimer's Research & Therapy. 9: 52. PMID 28750675 DOI: 10.1016/J.Jalz.2017.06.057 |
0.489 |
|
| 2017 |
van Waalwijk van Doorn LJC, Kulic L, Koel-Simmelink MJA, Kuiperij HB, Versleijen AAM, Struyfs H, Twaalfhoven HAM, Fourier A, Engelborghs S, Perret-Liaudet A, Lehmann S, Verbeek MM, Vanmechelen EJM, Teunissen CE. Multicenter Analytical Validation of Aβ40 Immunoassays. Frontiers in Neurology. 8: 310. PMID 28725210 DOI: 10.3389/Fneur.2017.00310 |
0.322 |
|
| 2017 |
Goossens J, Bjerke M, Struyfs H, Niemantsverdriet E, Somers C, Van den Bossche T, Van Mossevelde S, De Vil B, Sieben A, Martin JJ, Cras P, Goeman J, De Deyn PP, Van Broeckhoven C, van der Zee J, ... Engelborghs S, et al. No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis. Alzheimer's Research & Therapy. 9: 49. PMID 28709448 DOI: 10.1186/S13195-017-0275-5 |
0.488 |
|
| 2017 |
Bos I, Vos SJ, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Engelborghs S, Niemantsverdriet E, De Roeck EE, Tsolaki M, Freund-Levi Y, Johannsen P, Vandenberghe R, et al. The frequency and influence of dementia risk factors in prodromal Alzheimer's disease. Neurobiology of Aging. 56: 33-40. PMID 28482212 DOI: 10.1016/J.Neurobiolaging.2017.03.034 |
0.487 |
|
| 2017 |
Herukka SK, Simonsen AH, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, et al. Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 13: 285-295. PMID 28341066 DOI: 10.1016/J.Jalz.2016.09.009 |
0.502 |
|
| 2017 |
Simonsen AH, Herukka SK, Andreasen N, Baldeiras I, Bjerke M, Blennow K, Engelborghs S, Frisoni GB, Gabryelewicz T, Galluzzi S, Handels R, Kramberger MG, Kulczyńska A, Molinuevo JL, Mroczko B, et al. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 13: 274-284. PMID 28341065 DOI: 10.1016/J.Jalz.2016.09.008 |
0.48 |
|
| 2017 |
Ottoy J, Verhaeghe J, Niemantsverdriet E, Wyffels L, Somers C, De Roeck E, Struyfs H, Soetewey F, Deleye S, Van den Bossche T, Van Mossevelde S, Ceyssens S, Versijpt J, Stroobants S, Engelborghs S, et al. Validation of the semi-quantitative static SUVR method for [(18)F]-AV45 PET by pharmacokinetic modeling with an arterial input function. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28336779 DOI: 10.2967/Jnumed.116.184481 |
0.372 |
|
| 2017 |
Bosco P, Redolfi A, Bocchetta M, Ferrari C, Mega A, Galluzzi S, Austin M, Chincarini A, Collins DL, Duchesne S, Maréchal B, Roche A, Sensi F, Wolz R, Alegret M, ... ... Engelborghs S, et al. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28263741 DOI: 10.1016/J.Jalz.2017.01.019 |
0.473 |
|
| 2017 |
Willemse E, van Uffelen K, Brix B, Engelborghs S, Vanderstichele H, Teunissen C. How to handle adsorption of cerebrospinal fluid amyloid-β (1-42) in laboratory practice? Identifying problematic handlings and resolving the issue by use of the Aβ42/Aβ40 ratio. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28222302 DOI: 10.1016/J.Jalz.2017.01.010 |
0.32 |
|
| 2017 |
Timmers M, Barão S, Van Broeck B, Tesseur I, Slemmon J, De Waepenaert K, Bogert J, Shaw LM, Engelborghs S, Moechars D, Mercken M, Van Nueten L, Tritsmans L, de Strooper B, Streffer JR. BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer's Disease Markers in Elderly Healthy Participants. Journal of Alzheimer's Disease : Jad. PMID 28157093 DOI: 10.3233/Jad-160829 |
0.447 |
|
| 2017 |
Somers C, Goossens J, Engelborghs S, Bjerke M. Selecting Aβ isoforms for an Alzheimer's disease cerebrospinal fluid biomarker panel. Biomarkers in Medicine. PMID 28111962 DOI: 10.2217/Bmm-2016-0276 |
0.458 |
|
| 2017 |
Struyfs H, Pascoal TA, Ng KP, Mathotaarachchi SS, Benedet AL, Kang MS, Shin M, Therriault J, Billiet T, Smeets D, Ribbens A, Gauthier S, Bjerke M, Engelborghs S, Rosa-Neto P. The “A/T/N” System: Added Predictive Value Of N Biomarkers Of Progression From Mci To Dementia Over 2 And 4 Years Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.07.685 |
0.412 |
|
| 2017 |
Willemse EA, Vos AD, Herries EM, Andreasson U, Engelborghs S, Vanmechelen E, Flier WMvd, Scheltens P, Ladenson JH, Zetterberg H, Blennow K, Fagan AM, Bjerke M, Teunissen CE. Clinical Performance Of Neurogranin As A Cerebrospinal Fluid Biomarker For Alzheimer’S Disease: An Assay Comparison Study Alzheimers & Dementia. 13: 199. DOI: 10.1016/J.Jalz.2017.07.061 |
0.325 |
|
| 2017 |
Westwood S, Hye A, Lleó A, Nevado-Holgado AJ, Baird AL, Wallin A, Leslie A, Jimenez B, Liu BY, Legido-Quigley C, Dima D, Ruvolo D, Holmes E, D'Hondt E, Westman E, ... ... Engelborghs S, et al. DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER'S DISEASE PATHOLOGY AND PROGRESSION Alzheimer's & Dementia. 13: P174-P175. DOI: 10.1016/J.Jalz.2017.07.016 |
0.436 |
|
| 2017 |
Bos I, Vos SJB, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni GB, Molinuevo JL, Wallin A, Lleó A, Popp J, Martinez-Lage P, Baird AL, Legido-Quigley C, Bertram L, Barkhof F, et al. European Medical Information Framework For Alzheimer’S Disease (Emif-Ad): The Biomarker Discovery Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.864 |
0.367 |
|
| 2017 |
Tesseur I, Timmers M, Borjesson A, Broeck BV, Slemmon JR, Smekens P, Aguilar M, Baquero M, Frank A, Matias-Guiu J, Boada M, Hugon J, Prins ND, Laske C, Tritsmans L, ... ... Engelborghs S, et al. AMYLOID-β42 (Aβ42) DIFFERENTIALLY CORRELATES WITH CSF TOTAL AND HYPERPHOSPHORYLATED TAU IN AN AMYLOID-POSITIVE VERSUS AMYLOID-NEGATIVE EARLY PRODROMAL AND ASYMPTOMATIC AT-RISK FOR AD POPULATION Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.863 |
0.392 |
|
| 2017 |
Vos SJB, Gronenschild E, Jacobs HIL, Bos I, Scheltens P, Niemantsverdriet E, Engelborghs S, Verhey FRJ, Visser PJ. Characterization Of Suspected Non-Alzheimer’S Disease Pathophysiology (Snap) In Individuals With Mild Cognitive Impairment Using Neuroimaging Alzheimers & Dementia. 13: 414. DOI: 10.1016/J.Jalz.2017.06.403 |
0.399 |
|
| 2017 |
Westwood S, Baird AL, Hye A, Bos I, Vos SJ, Vandenberghe R, Scheltens P, Engelborghs S, Frisoni GB, Molinuevo JL, Wallin A, Lleó A, Popp J, Martinez-Lage P, Snowden SG, et al. [P1-289]: DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN (CSF Aβ OR AMYLOID-PET) IN THE EMIF-AD BIOMARKER DISCOVERY COHORT Alzheimer's & Dementia. 13: P361-P362. DOI: 10.1016/J.Jalz.2017.06.305 |
0.407 |
|
| 2017 |
Struyfs H, Pascoal TA, Ng KP, Mathotaarachchi SS, Shin M, Kang MS, Therriault J, Smeets D, Ribbens A, Gauthier S, Bjerke M, Engelborghs S, Rosa-Neto P. Fdg-Pet Power To Predict Memory Decline In Alzheimer’S Disease Depends On Disease Phase And Amyloid And Tau Status Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.2107 |
0.32 |
|
| 2017 |
Abbott RA, Cormack FK, Engelborghs S, Timmers M, Randolph C, Zavitz K, Streffer J. [P4-158]: PRE-SCREENING FOR EPISODIC MEMORY DEFICITS CAN ENRICH FOR ELIGIBLE SUBJECTS IN EARLY ALZHEIMER's DISEASE CLINICAL TRIALS Alzheimer's & Dementia. 13: P1319-P1320. DOI: 10.1016/J.Jalz.2017.06.2025 |
0.363 |
|
| 2017 |
Mossevelde SV, Zee Jvd, Steger C, Verwilligen L, Cras P, Engelborghs S, Broeckhoven CV. The Mapt P.Arg406Trp Is A Founder Mutation In Belgium And Presents With An Alzheimer Disease Dementia-Like Phenotype Alzheimers & Dementia. 13: 1286. DOI: 10.1016/J.Jalz.2017.06.1940 |
0.455 |
|
| 2017 |
Perrone F, Cacace R, Mossevelde SV, Bossche TVd, Sieben A, Engelborghs S, Cras P, Deyn PPD, Martin J, Zee Jvd, Broeckhoven CV. A Prospective Neurogenetic Study On Early-Onset Dementia In Patients With Unclear Initial Diagnosis Of Degenerative Dementia Alzheimers & Dementia. 13: 1284. DOI: 10.1016/J.Jalz.2017.06.1934 |
0.468 |
|
| 2017 |
Van Waes L, Leijten M, Mariën P, Engelborghs S. Typing competencies in Alzheimer's disease: An exploration of copy tasks Computers in Human Behavior. 73: 311-319. DOI: 10.1016/J.Chb.2017.03.050 |
0.338 |
|
| 2016 |
Perrone F, Nguyen HP, Van Mossevelde S, Moisse M, Sieben A, Santens P, De Bleecker J, Vandenbulcke M, Engelborghs S, Baets J, Cras P, Vandenberghe R, De Jonghe P, De Deyn PP, Martin JJ, et al. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients. Neurobiology of Aging. PMID 28069311 DOI: 10.1016/J.Neurobiolaging.2016.12.008 |
0.379 |
|
| 2016 |
Verslegers L, Schotsmans K, Montagna M, Feyen B, De Jong L, Crols R, Engelborghs S. Severe bilateral subdural hematomas as a complication of diagnostic lumbar puncture for possible Alzheimer's disease. Clinical Neurology and Neurosurgery. 152: 95-96. PMID 27978461 DOI: 10.1016/J.Clineuro.2016.12.003 |
0.432 |
|
| 2016 |
Dekens DW, Naudé PJ, Engelborghs S, Vermeiren Y, Van Dam D, Oude Voshaar RC, Eisel UL, De Deyn PP. Neutrophil Gelatinase-Associated Lipocalin and its Receptors in Alzheimer's Disease (AD) Brain Regions: Differential Findings in AD with and without Depression. Journal of Alzheimer's Disease : Jad. PMID 27716662 DOI: 10.3233/Jad-160330 |
0.42 |
|
| 2016 |
van der Zee J, Mariën P, Crols R, Van Mossevelde S, Dillen L, Perrone F, Engelborghs S, Verhoeven J, D'aes T, Ceuterick-De Groote C, Sieben A, Versijpt J, Cras P, Martin JJ, Van Broeckhoven C. Mutated CTSF in adult-onset neuronal ceroid lipofuscinosis and FTD. Neurology. Genetics. 2: e102. PMID 27668283 DOI: 10.1212/Nxg.0000000000000102 |
0.323 |
|
| 2016 |
Arnerić SP, Batrla-Utermann R, Beckett L, Bittner T, Blennow K, Carter L, Dean R, Engelborghs S, Genius J, Gordon MF, Hitchcock J, Kaplow J, Luthman J, Meibach R, Raunig D, et al. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team. Journal of Alzheimer's Disease : Jad. PMID 27662307 DOI: 10.3233/Jad-160573 |
0.45 |
|
| 2016 |
Lewczuk P, Lelental N, Lachmann I, Holzer M, Flach K, Brandner S, Engelborghs S, Teunissen CE, Zetterberg H, Molinuevo JL, Mroczko B, Blennow K, Popp J, Parnetti L, Chiasserini D, et al. Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization. Journal of Alzheimer's Disease : Jad. PMID 27662295 DOI: 10.3233/Jad-160448 |
0.408 |
|
| 2016 |
Goossens J, Laton J, Van Schependom J, Gielen J, Struyfs H, Van Mossevelde S, Van den Bossche T, Goeman J, De Deyn PP, Sieben A, Martin JJ, Van Broeckhoven C, van der Zee J, Engelborghs S, Nagels G. EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar Degeneration. Journal of Alzheimer's Disease : Jad. PMID 27636837 DOI: 10.1016/J.Jalz.2016.06.656 |
0.418 |
|
| 2016 |
Somers C, Struyfs H, Goossens J, Niemantsverdriet E, Luyckx J, De Roeck N, De Roeck E, De Vil B, Cras P, Martin JJ, De Deyn PP, Bjerke M, Engelborghs S. A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium. Journal of Alzheimer's Disease : Jad. 54: 383-95. PMID 27567807 DOI: 10.1016/J.Jalz.2016.06.918 |
0.506 |
|
| 2016 |
Crosiers D, Verstraeten A, Wauters E, Engelborghs S, Peeters K, Mattheijssens M, De Deyn PP, Theuns J, Van Broeckhoven C, Cras P. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort. Neuroscience Letters. PMID 27397011 DOI: 10.1016/J.Neulet.2016.07.008 |
0.343 |
|
| 2016 |
De Vos A, Struyfs H, Jacobs D, Fransen E, Klewansky T, De Roeck E, Robberecht C, Van Broeckhoven C, Duyckaerts C, Engelborghs S, Vanmechelen E. The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27392859 DOI: 10.3233/Jad-160227 |
0.487 |
|
| 2016 |
Van Broeck B, Timmers M, Ramael S, Bogert J, Shaw LM, Mercken M, Slemmon J, Van Nueten L, Engelborghs S, Streffer JR. Impact of frequent cerebrospinal fluid sampling on Aβ levels: systematic approach to elucidate influencing factors. Alzheimer's Research & Therapy. 8: 21. PMID 27206648 DOI: 10.1186/S13195-016-0184-Z |
0.366 |
|
| 2016 |
Müller M, Kuiperij HB, Versleijen AA, Chiasserini D, Farotti L, Baschieri F, Parnetti L, Struyfs H, De Roeck N, Luyckx J, Engelborghs S, Claassen JA, Verbeek MM. Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study. Journal of Alzheimer's Disease : Jad. PMID 27104900 DOI: 10.3233/Jad-160038 |
0.387 |
|
| 2016 |
Verheijen J, Van den Bossche T, van der Zee J, Engelborghs S, Sanchez-Valle R, Lladó A, Graff C, Thonberg H, Pastor P, Ortega-Cubero S, Pastor MA, Benussi L, Ghidoni R, Binetti G, Clarimon J, et al. A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's disease. Acta Neuropathologica. PMID 27026413 DOI: 10.1007/S00401-016-1566-9 |
0.409 |
|
| 2016 |
De Roeck EE, Engelborghs S, Dierckx E. Next Generation Brain Health Depends on Early Alzheimer Disease Diagnosis: From a Timely Diagnosis to Future Population Screening. Journal of the American Medical Directors Association. 17: 452-3. PMID 26972349 DOI: 10.1016/J.Jamda.2016.02.015 |
0.325 |
|
| 2016 |
Lelental N, Brandner S, Kofanova O, Blennow K, Zetterberg H, Andreasson U, Engelborghs S, Mroczko B, Gabryelewicz T, Teunissen C, Mollenhauer B, Parnetti L, Chiasserini D, Molinuevo JL, Perret-Liaudet A, et al. Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics. Journal of Alzheimer's Disease : Jad. PMID 26967210 DOI: 10.3233/Jad-150883 |
0.316 |
|
| 2016 |
Suárez-Calvet M, Kleinberger G, Araque Caballero MÁ, Brendel M, Rominger A, Alcolea D, Fortea J, Lleó A, Blesa R, Gispert JD, Sánchez-Valle R, Antonell A, Rami L, Molinuevo JL, Brosseron F, ... ... Engelborghs S, et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers. Embo Molecular Medicine. PMID 26941262 DOI: 10.15252/Emmm.201506123 |
0.472 |
|
| 2016 |
Niemantsverdriet E, Goossens J, Struyfs H, Martin JJ, Goeman J, De Deyn PP, Vanderstichele H, Engelborghs S. Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 51: 97-106. PMID 26836187 DOI: 10.3233/Jad-150953 |
0.489 |
|
| 2016 |
De Roeck E, Ponjaert-Kristoffersen I, Bosmans M, De Deyn PP, Engelborghs S, Dierckx E. Are depressive symptoms in mild cognitive impairment predictive of conversion to dementia? International Psychogeriatrics / Ipa. 28: 921-8. PMID 26778529 DOI: 10.1017/S1041610215002409 |
0.399 |
|
| 2016 |
van Waalwijk van Doorn LJ, Koel-Simmelink MJ, Haußmann U, Klafki H, Struyfs H, Linning P, Knölker HJ, Twaalfhoven H, Kuiperij HB, Engelborghs S, Scheltens P, Verbeek MM, Vanmechelen E, Wiltfang J, Teunissen CE. Validation of soluble APP assays as diagnostic CSF biomarkers for neurodegenerative diseases. Journal of Neurochemistry. PMID 26748905 DOI: 10.1111/Jnc.13527 |
0.311 |
|
| 2016 |
Struyfs H, Vanmechelen E, De Roeck EE, Fransen E, Niemantsverdriet E, Somers C, Goossens J, De Vos A, Herbst V, Van den Bossche T, Van Mossevelde S, Goeman J, de Deyn PP, Bjerke M, Engelborghs S. P4-322: CSF Biomarkers to Predict Rate of Cognitive Decline in Alzheimer’S Disease Alzheimer's & Dementia. 12: P1157-P1157. DOI: 10.1016/J.Jalz.2016.07.066 |
0.393 |
|
| 2016 |
Niemantsverdriet E, Van den Bossche T, Van Mossevelde S, Ottoy J, Verhaeghe J, Somers C, De Roeck EE, Struyfs H, Deleye S, Goeman J, Versijpt J, Paul de Deyn P, Mariën P, Wyffels L, Bjerke M, ... ... Engelborghs S, et al. P4-314: Discordance Between Amyloid-PET and CSF Amyloid-β for Diagnosing Alzheimer’S Disease in a Clinical Setting Alzheimer's & Dementia. 12: P1154-P1154. DOI: 10.1016/J.Jalz.2016.07.057 |
0.37 |
|
| 2016 |
Goossens J, van der Zee J, Van Mossevelde S, Vanmechelen E, Van den Bossche T, De Vil B, Sieben A, Martin J, Cras P, Goeman J, de Deyn PP, Van Broeckhoven C, Engelborghs S. P1-176: CSF Exploratory Biomarker Study for (DIFFERENTIAL) Diagnosis of Frontotemporal Lobar Degeneration Alzheimer's & Dementia. 12: P471-P471. DOI: 10.1016/J.Jalz.2016.06.924 |
0.349 |
|
| 2016 |
Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S, Mollenhauer B, Engelborghs S, Tambasco N, Calabresi P, Parnetti L, Chiasserini D. Combination Of Cerebrospinal Fluid H-Fabp And Core Alzheimer'S Disease Biomarkers Improves The Differential Diagnosis Of Neurodegenerative Disorders Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.353 |
0.367 |
|
| 2016 |
Streffer J, Börjesson-Hanson A, Van Broeck B, Smekens P, Timmers M, Tesseur I, Tatikola K, Russu A, Sinha V, Salvadore G, Aguilar M, Frank A, Matias-Guiu J, Boada M, Baquero M, ... ... Engelborghs S, et al. O1-10-05: Pharmacodynamics of the Oral Bace Inhibitor JNJ-54861911 in Early Alzheimer's Disease Alzheimer's & Dementia. 12: P199-P200. DOI: 10.1016/J.Jalz.2016.06.350 |
0.35 |
|
| 2016 |
Goossens J, Van Mossevelde S, Van den Bossche T, Sieben A, Martin J, Goeman J, Paul de Deyn P, Van Broeckhoven C, van der Zee J, Engelborghs S. P4-120: Increased CSF Levels of Biomarkers for Neurodegeneration in FTLD-GRN Mutation Carriers Alzheimer's & Dementia. 12: P1058-P1059. DOI: 10.1016/J.Jalz.2016.06.2211 |
0.306 |
|
| 2016 |
Bosco P, Redolfi A, Bocchetta M, Ferrari C, Mega A, Galluzzi S, Assal F, Balasa M, Bastin C, Bougea A, Emek-Savas DD, Engelborghs S, Giannakopoulos P, Gold G, Grimmer T, et al. Impact of biomarkers on diagnostic confidence in clinical assessment of patients with suspected Alzheimer’s disease and high diagnostic uncertainty: An EADC study Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.1871 |
0.328 |
|
| 2016 |
De Roeck EE, Paul de Deyn P, Engelborghs S, Dierckx E. P2-299: Brief Neuropsychological Screening Tests for the Detection of Alzheimer's Disease in an Early Phase: A Systematic Review Alzheimer's & Dementia. 12: P748-P748. DOI: 10.1016/J.Jalz.2016.06.1559 |
0.357 |
|
| 2016 |
Goossens J, Struyfs H, Niemantsverdriet E, Van den Bossche T, Van Mossevelde S, De Vil B, Sieben A, Martin J, Cras P, Goeman J, Paul de Deyn P, Van Broeckhoven C, van der Zee J, Engelborghs S. P2-153: Diagnostic Performance of Non-Phosphorylated TAU Fraction (PTAU REL) in CSF as Biomarker for Differential Dementia Diagnosis Alzheimer's & Dementia. 12: P672-P673. DOI: 10.1016/J.Jalz.2016.06.1320 |
0.407 |
|
| 2016 |
De Roeck EE, De Witte N, Dury S, Paul de Deyn P, Dierckx E, Engelborghs S. P1-407: Cognitive Frailty: A New Domain Added to The Comprehensive Frailty Assessment Alzheimer's & Dementia. 12: P590-P590. DOI: 10.1016/J.Jalz.2016.06.1159 |
0.411 |
|
| 2015 |
Van Mossevelde S, van der Zee J, Gijselinck I, Engelborghs S, Sieben A, Van Langenhove T, De Bleecker J, Baets J, Vandenbulcke M, Van Laere K, Ceyssens S, Van den Broeck M, Peeters K, Mattheijssens M, Cras P, et al. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort. Brain : a Journal of Neurology. PMID 26674655 DOI: 10.1093/Brain/Awv358 |
0.337 |
|
| 2015 |
Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Philtjens S, Heeman B, Engelborghs S, Vandenbulcke M, De Baets G, Bäumer V, Cuijt I, Van den Broeck M, Peeters K, Mattheijssens M, Rousseau F, et al. Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology. PMID 26581300 DOI: 10.1212/Wnl.0000000000002220 |
0.343 |
|
| 2015 |
Struyfs H, Van Hecke W, Veraart J, Sijbers J, Slaets S, De Belder M, Wuyts L, Peters B, Sleegers K, Robberecht C, Van Broeckhoven C, De Belder F, Parizel PM, Engelborghs S. Diffusion Kurtosis Imaging: A Possible MRI Biomarker for AD Diagnosis? Journal of Alzheimer's Disease : Jad. 48: 937-48. PMID 26444762 DOI: 10.3233/Jad-150253 |
0.412 |
|
| 2015 |
Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, et al. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. Brain : a Journal of Neurology. 138: 2701-15. PMID 26220940 DOI: 10.1093/Brain/Awv199 |
0.41 |
|
| 2015 |
Bettens K, Vermeulen S, Van Cauwenberghe C, Heeman B, Asselbergh B, Robberecht C, Engelborghs S, Vandenbulcke M, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, Sleegers K. Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations. Molecular Neurodegeneration. 10: 30. PMID 26179372 DOI: 10.1186/S13024-015-0024-9 |
0.394 |
|
| 2015 |
Cuyvers E, De Roeck A, Van den Bossche T, Van Cauwenberghe C, Bettens K, Vermeulen S, Mattheijssens M, Peeters K, Engelborghs S, Vandenbulcke M, Vandenberghe R, De Deyn PP, Van Broeckhoven C, Sleegers K. Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study. The Lancet. Neurology. 14: 814-22. PMID 26141617 DOI: 10.1016/S1474-4422(15)00133-7 |
0.41 |
|
| 2015 |
Struyfs H, Niemantsverdriet E, Goossens J, Fransen E, Martin JJ, De Deyn PP, Engelborghs S. Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis. Frontiers in Neurology. 6: 138. PMID 26136723 DOI: 10.3389/Fneur.2015.00138 |
0.47 |
|
| 2015 |
De Vos A, Jacobs D, Struyfs H, Fransen E, Andersson K, Portelius E, Andreasson U, De Surgeloose D, Hernalsteen D, Sleegers K, Robberecht C, Van Broeckhoven C, Zetterberg H, Blennow K, Engelborghs S, et al. C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26092348 DOI: 10.1016/J.Jalz.2015.05.012 |
0.403 |
|
| 2015 |
Sleegers K, Bettens K, De Roeck A, Van Cauwenberghe C, Cuyvers E, Verheijen J, Struyfs H, Van Dongen J, Vermeulen S, Engelborghs S, Vandenbulcke M, Vandenberghe R, De Deyn PP, Van Broeckhoven C. A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 11: 1452-60. PMID 26086184 DOI: 10.1016/J.Jalz.2015.02.013 |
0.431 |
|
| 2015 |
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, ... ... Engelborghs S, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/Jama.2015.4668 |
0.821 |
|
| 2015 |
Le Bastard N, De Deyn PP, Engelborghs S. Importance and impact of preanalytical variables on Alzheimer disease biomarker concentrations in cerebrospinal fluid. Clinical Chemistry. 61: 734-43. PMID 25869575 DOI: 10.1373/Clinchem.2014.236679 |
0.385 |
|
| 2015 |
Cuyvers E, van der Zee J, Bettens K, Engelborghs S, Vandenbulcke M, Robberecht C, Dillen L, Merlin C, Geerts N, Graff C, Thonberg H, Chiang HH, Pastor P, Ortega-Cubero S, Pastor MA, et al. Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study. Neurobiology of Aging. 36: 2005.e15-22. PMID 25796131 DOI: 10.1016/J.Neurobiolaging.2015.02.014 |
0.47 |
|
| 2015 |
Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, Martin JJ, De Deyn PP. The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease. Alzheimer's Research & Therapy. 7: 7. PMID 25717350 DOI: 10.1186/S13195-014-0090-1 |
0.481 |
|
| 2015 |
Vos SJ, Verhey F, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Nobili F, Morbelli S, Frisoni GB, Drzezga A, Didic M, van Berckel BN, Simmons A, ... ... Engelborghs S, et al. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. Brain : a Journal of Neurology. 138: 1327-38. PMID 25693589 DOI: 10.1093/Brain/Awv029 |
0.824 |
|
| 2015 |
Niemantsverdriet E, Feyen BF, Le Bastard N, Martin JJ, Goeman J, De Deyn PP, Engelborghs S. Overdiagnosing Vascular Dementia using Structural Brain Imaging for Dementia Work-Up. Journal of Alzheimer's Disease : Jad. 45: 1039-43. PMID 25633672 DOI: 10.3233/Jad-142103 |
0.444 |
|
| 2015 |
Struyfs H, Van Broeck B, Timmers M, Fransen E, Sleegers K, Van Broeckhoven C, De Deyn PP, Streffer JR, Mercken M, Engelborghs S. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis. Journal of Alzheimer's Disease : Jad. 45: 813-22. PMID 25633670 DOI: 10.3233/Jad-141986 |
0.461 |
|
| 2015 |
Bier JC, Verschraegen J, Vandenberghe R, Guillaume B, Picard G, Otte G, Mormont E, Gilles C, Segers K, Sieben A, Thiery E, Ventura M, De Deyn P, Deryck O, Versijpt J, ... ... Engelborghs S, et al. Clinical utility and applicability of biomarker-based diagnostic criteria for Alzheimer's disease: a BeDeCo survey. Acta Neurologica Belgica. PMID 25576445 DOI: 10.1007/S13760-014-0423-7 |
0.327 |
|
| 2015 |
Dorey A, Tholance Y, Vighetto A, Perret-Liaudet A, Lachman I, Krolak-Salmon P, Wagner U, Struyfs H, De Deyn PP, El-Moualij B, Zorzi W, Meyronet D, Streichenberger N, Engelborghs S, Kovacs GG, et al. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease. Jama Neurology. 72: 267-75. PMID 25559883 DOI: 10.1001/Jamaneurol.2014.4068 |
0.478 |
|
| 2015 |
Rosseels J, Van den Brande J, Violet M, Jacobs D, Grognet P, Lopez J, Huvent I, Caldara M, Swinnen E, Papegaey A, Caillierez R, Buée-Scherrer V, Engelborghs S, Lippens G, Colin M, et al. Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics. The Journal of Biological Chemistry. 290: 4059-74. PMID 25540200 DOI: 10.1074/Jbc.M114.627919 |
0.381 |
|
| 2015 |
Slaets S, Van Acker F, Versijpt J, Hauth L, Goeman J, Martin JJ, De Deyn PP, Engelborghs S. Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis. International Journal of Geriatric Psychiatry. 30: 864-9. PMID 25363642 DOI: 10.1002/Gps.4229 |
0.401 |
|
| 2015 |
Van der Mussele S, Mariën P, Saerens J, Somers N, Goeman J, De Deyn PP, Engelborghs S. Psychosis associated behavioral and psychological signs and symptoms in mild cognitive impairment and Alzheimer's dementia. Aging & Mental Health. 19: 818-28. PMID 25323000 DOI: 10.1080/13607863.2014.967170 |
0.834 |
|
| 2015 |
Van der Mussele S, Le Bastard N, Saerens J, Somers N, Mariën P, Goeman J, De Deyn PP, Engelborghs S. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia. Aging & Mental Health. 19: 247-57. PMID 24962058 DOI: 10.1080/13607863.2014.924900 |
0.837 |
|
| 2015 |
Ribbens A, Smeets D, Terzopoulos V, Jain S, Sima DM, Struyfs H, Engelborghs S, Hecke WV. Admetrix: A new method for atrophy quantification in Alzheimer's disease Alzheimers & Dementia. 11: 876. DOI: 10.1016/J.Jalz.2015.08.078 |
0.398 |
|
| 2015 |
Struyfs H, Smeets D, Terzopoulos V, Slaets S, Wuyts L, Peters B, De Belder F, Parizel PM, Van Hecke W, Engelborghs S. P4-248: Resting state functional MRI as a possible biomarker for Alzheimer's disease: An innovative approach for robust extraction of the default mode network Alzheimer's & Dementia. 11: P876-P876. DOI: 10.1016/J.Jalz.2015.08.077 |
0.343 |
|
| 2015 |
Sleegers K, Verheijen J, Zee Jvd, Bettens K, Engelborghs S, Vandenbulcke M, Sanchez-Valle R, Benussi L, Mendonça Ad, Pastor P, Graff C, Borroni B, Vandenberghe R, Deyn PPD, Broeckhoven CV. Targeted re-sequencing of sorl1 in early-onset Alzheimer’s dementia: The european early onset dementia consortium Alzheimers & Dementia. 11: 253. DOI: 10.1016/J.Jalz.2015.07.484 |
0.404 |
|
| 2015 |
Niemantsverdriet E, Goossens J, Struyfs H, Martin J, Goeman J, De Deyn PP, Vanderstichele HM, Engelborghs S. O4-11-03: Limited impact of CSF biomarkers variability on clinical diagnosis in autopsy-confirmed Alzheimer's disease Alzheimer's & Dementia. 11: P296-P297. DOI: 10.1016/J.Jalz.2015.07.407 |
0.387 |
|
| 2015 |
Vanderstichele HM, Stephenson D, Shaw LM, Carrillo M, Umek R, Rajapakse H, Luthman J, Soares H, Gordon MF, Devanarayan V, Genius J, Berman R, Hendrix J, Romero K, Kaplow J, ... ... Engelborghs S, et al. O4-11-02: The path to regulatory qualification of cerebrospinal fluid biomarkers as enrichment tools in clinical trials of patients with early Alzheimer's disease: For the coalition against major diseases Alzheimer's & Dementia. 11: P296-P296. DOI: 10.1016/J.Jalz.2015.07.406 |
0.384 |
|
| 2015 |
Cacace R, Van den Bossche T, Engelborghs S, Vandenbulcke M, Vandenberghe R, De Deyn PP, Cras P, Sleegers K, Van Broeckhoven C. P3-017: Rare variants in PLD3
do not increase risk in a belgian cohort of early-onset Alzheimer dementia patients Alzheimer's & Dementia. 11: P626-P626. DOI: 10.1016/J.Jalz.2015.06.883 |
0.454 |
|
| 2015 |
Stoops E, Demeyer L, Engelborghs S, Struyfs H, Niemantsverdriet E, Sleegers K, Herbst V, Zerr I, Schmitz M, Van Broeckhoven C, Vanderstichele H. P2-072: Development of novel elisas for the quantification of both pan-ApoE and ApoE4 proteins in CSF and blood, and ApoE
ε4 phenotyping Alzheimer's & Dementia. 11: P510-P510. DOI: 10.1016/J.Jalz.2015.06.609 |
0.321 |
|
| 2015 |
Novak GP, Gordon MF, Li DJ, Alexander M, Schaerer J, Roche F, Engelborghs S, Dubois B. Operationalizing the iwg2 and nia-aa diagnostic criteria for asymptomatic-at-risk for Alzheimer's disease or preclinical Alzheimer's disease Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.380 |
0.434 |
|
| 2015 |
Doorn LJCvWv, Koel-Simmelink MJ, Hausmann U, Klafki H, Struyfs H, Linning P, Knoelker H, Twaalfhoven H, Kuiperij HB, Vanmechelen E, Verbeek M, Engelborghs S, Wiltfang J, Teunissen CE. Standardization of a method for diagnostic biomarker validation for neurodegenerative diseases: App assays as example Alzheimers & Dementia. 11: 387. DOI: 10.1016/J.Jalz.2015.06.318 |
0.329 |
|
| 2014 |
Molinuevo JL, Blennow K, Dubois B, Engelborghs S, Lewczuk P, Perret-Liaudet A, Teunissen CE, Parnetti L. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 808-17. PMID 25150736 DOI: 10.1016/J.Jalz.2014.03.003 |
0.497 |
|
| 2014 |
Van der Mussele S, Fransen E, Struyfs H, Luyckx J, Mariën P, Saerens J, Somers N, Goeman J, De Deyn PP, Engelborghs S. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study. Journal of Alzheimer's Disease : Jad. 42: 1239-50. PMID 25024328 DOI: 10.3233/Jad-140405 |
0.827 |
|
| 2014 |
Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, De Deyn PP. Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease. Neurobiology of Aging. 35: 2691-700. PMID 24997673 DOI: 10.1016/J.Neurobiolaging.2014.05.031 |
0.428 |
|
| 2014 |
Kleinberger G, Yamanishi Y, Suárez-Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger-Weinzierl A, Mazaheri F, Tahirovic S, Lleó A, Alcolea D, Fortea J, Willem M, ... ... Engelborghs S, et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Science Translational Medicine. 6: 243ra86. PMID 24990881 DOI: 10.1126/Scitranslmed.3009093 |
0.302 |
|
| 2014 |
Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet. Neurology. 13: 614-29. PMID 24849862 DOI: 10.1016/S1474-4422(14)70090-0 |
0.376 |
|
| 2014 |
Struyfs H, Molinuevo JL, Martin JJ, De Deyn PP, Engelborghs S. Validation of the AD-CSF-index in autopsy-confirmed Alzheimer's disease patients and healthy controls. Journal of Alzheimer's Disease : Jad. 41: 903-9. PMID 24705548 DOI: 10.3233/Jad-131085 |
0.47 |
|
| 2014 |
Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, De Deyn PP. Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 41: 819-33. PMID 24685637 DOI: 10.3233/Jad-140309 |
0.445 |
|
| 2014 |
Engelborghs S, Gilles C, Ivanoiu A, Vandewoude M. Rationale and clinical data supporting nutritional intervention in Alzheimer's disease Acta Clinica Belgica. 69: 17-24. PMID 24635394 DOI: 10.1179/0001551213Z.0000000006 |
0.321 |
|
| 2014 |
Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, ... ... Engelborghs S, et al. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathologica. 127: 407-18. PMID 24442578 DOI: 10.1007/S00401-013-1239-X |
0.313 |
|
| 2014 |
Slaets S, Vanmechelen E, Le Bastard N, Decraemer H, Vandijck M, Martin JJ, De Deyn PP, Engelborghs S. Increased CSF α-synuclein levels in Alzheimer's disease: correlation with tau levels. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: S290-8. PMID 24439167 DOI: 10.1016/J.Jalz.2013.10.004 |
0.472 |
|
| 2014 |
Teunissen CE, Tumani H, Engelborghs S, Mollenhauer B. Biobanking of CSF: international standardization to optimize biomarker development. Clinical Biochemistry. 47: 288-92. PMID 24389077 DOI: 10.1016/J.Clinbiochem.2013.12.024 |
0.303 |
|
| 2014 |
Cuyvers E, Bettens K, Philtjens S, Van Langenhove T, Gijselinck I, van der Zee J, Engelborghs S, Vandenbulcke M, Van Dongen J, Geerts N, Maes G, Mattheijssens M, Peeters K, Cras P, Vandenberghe R, et al. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia. Neurobiology of Aging. 35: 726.e11-9. PMID 24119542 DOI: 10.1016/J.Neurobiolaging.2013.09.009 |
0.392 |
|
| 2014 |
Van der Mussele S, Mariën P, Saerens J, Somers N, Goeman J, De Deyn PP, Engelborghs S. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 38: 319-29. PMID 23963290 DOI: 10.3233/Jad-130596 |
0.814 |
|
| 2014 |
Engelborghs S, Slaets S, Acker FV, Versijpt J, Hauth L, Martin J, Deyn PPD. The Diagnostic Value Of Mibg Cardiac Scintigraphy For Differential Dementia Diagnosis Alzheimers & Dementia. 10: 544. DOI: 10.1016/J.Jalz.2014.05.874 |
0.325 |
|
| 2014 |
Engelborghs S, Niemantsverdriet E, Feyen B, Martin J, Goeman J, De Deyn PP. P2-197: VASCULAR DEMENTIA IS OVERDIAGNOSED WHEN STRUCTURAL BRAIN IMAGING IS USED IN THE CONTEXT OF STANDARD CLINICAL DIAGNOSTIC CRITERIA FOR DEMENTIA Alzheimer's & Dementia. 10: P543-P544. DOI: 10.1016/J.Jalz.2014.05.873 |
0.4 |
|
| 2014 |
Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, De Deyn PP. P2-148: MONOAMINERGIC NEUROTRANSMITTER LEVELS IN POST-MORTEM BRAIN REGIONS OF PATIENTS WITH LEWY BODY AND ALZHEIMER'S DEMENTIA: ASSOCIATION WITH DEPRESSION AND PSYCHOSIS Alzheimer's & Dementia. 10: P526-P526. DOI: 10.1016/J.Jalz.2014.05.823 |
0.39 |
|
| 2014 |
Vanderstichele H, Demeyer L, Stoops E, Mauroo K, Struyfs H, Herbst V, Engelborghs S, Brix B. QUANTIFICATION OF CSF Aβ1-38, TOGETHER WITH APOLIPOPROTEINS E, CAN IMPROVE THE CLINICAL DIAGNOSTIC ACCURACY FOR AD OF THE CSF TAU AND Aβ ASSAYS Alzheimers & Dementia. 10: 512. DOI: 10.1016/J.Jalz.2014.05.787 |
0.519 |
|
| 2014 |
Dierckx E, Engelborghs S, Deyn PPD, Mussele SVd, Ponjaert-Kristoffersen I. The Montreal Cognitive Assessment Instrument: Influence Of Depressive Symptoms Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.583 |
0.334 |
|
| 2014 |
Van Broeck B, Struyfs H, Timmers M, Sleegers K, Van Broeckhoven C, De Deyn PP, Streffer JR, Mercken M, Engelborghs S. P1-136: DIAGNOSTIC ACCURACY OF CSF AMYLOID-B ISOFORMS FOR EARLY AND DIFFERENTIAL DEMENTIA DIAGNOSIS Alzheimer's & Dementia. 10: P349-P350. DOI: 10.1016/J.Jalz.2014.05.373 |
0.41 |
|
| 2014 |
Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, De Deyn PP. P1-112: MONOAMINERGIC BRAIN TOPOCHEMISTRY IN ALZHEIMER'S DISEASE VERSUS HEALTHY ELDERLY Alzheimer's & Dementia. 10: P342-P342. DOI: 10.1016/J.Jalz.2014.05.349 |
0.411 |
|
| 2014 |
Van Cauwenberghe C, Bettens K, Engelborghs S, Vandenbulcke M, Vandenberghe RR, De Deyn PP, Cruts M, Van Broeckhoven C, Sleegers K. P1-053: OLFACTORY RECEPTOR COPY NUMBER VARIATION INVOLVED IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P322-P323. DOI: 10.1016/J.Jalz.2014.05.289 |
0.365 |
|
| 2014 |
Soetewey F, Struyfs H, Stoops E, Van Broeckhoven C, Vanderstichele H, Engelborghs S. P4-068: CLINICAL RELEVANCE OF APOE GENOTYPING AND APOLIPOPROTEIN E-ɛ4 IMMUNOASSAYS IN ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P808-P808. DOI: 10.1016/J.Jalz.2014.05.1583 |
0.417 |
|
| 2014 |
Vanderstichele H, Vanderstichele H, Devanarayan V, Shaw L, Jeromin A, Coart E, Engelborghs S. P4-058: IMPACT OF ANALYTICAL BIAS AND IMPRECISION OF CSF BIOMARKERS ON THEIR CLINICAL DIAGNOSTIC PERFORMANCE FOR AD DIAGNOSIS Alzheimer's & Dementia. 10: P803-P803. DOI: 10.1016/J.Jalz.2014.05.1573 |
0.397 |
|
| 2014 |
Van der Mussele S, Fransen E, Mariën P, Saerens J, Somers N, Goeman J, De Deyn PP, Engelborghs S. P3-154: BEHAVIORAL SYMPTOMS ASSOCIATED WITH PROGRESSION FROM MILD COGNITIVE IMPAIRMENT TO ALZHEIMER'S DISEASE: A LONGITUDINAL STUDY Alzheimer's & Dementia. 10: P684-P685. DOI: 10.1016/J.Jalz.2014.05.1244 |
0.508 |
|
| 2014 |
Marreiro A, Kolen KV, Plasman K, Depuydt G, Peeraer E, Daneels G, Fierens K, Temmerman L, Vandermeeren M, Hermans B, Deyn PPD, Engelborghs S, Gevaert K, Moechars D, Mercken M. Molecular Analysis of Tau in Rodent and Non-Rodent Models of Ad Alzheimers & Dementia. 10: 649. DOI: 10.1016/J.Jalz.2014.05.1147 |
0.39 |
|
| 2014 |
Bettens K, Cauwenberghe CV, Cuyvers E, Verheijen J, Roeck AD, Dongen JV, Vermeulen S, Engelborghs S, Vandenbulcke M, Vandenberghe RR, Deyn PPD, Broeckhoven CV, Sleegers K. HIGH SCORES ON A 22-GENE RISK SCORE FOR ALZHEIMER'S DEMENTIA CORRELATE WITH EARLIER ONSET AGE AND REDUCED CSF Aβ Alzheimers & Dementia. 10: 257. DOI: 10.1016/J.Jalz.2014.04.404 |
0.44 |
|
| 2014 |
Struyfs H, Van Hecke W, Slaets S, Van der Mussele S, De Belder M, Wuyts L, Peters B, De Belder F, Parizel P, Engelborghs S. O2-03-06: DIFFUSION KURTOSIS IMAGING: A BIOMARKER FOR EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE? Alzheimer's & Dementia. 10: P169-P170. DOI: 10.1016/J.Jalz.2014.04.172 |
0.347 |
|
| 2014 |
Struyfs H, Molinuevo JL, Martin J, De Deyn PP, Engelborghs S. O1-09-05: VALIDATION OF THE AD-CSF INDEX IN AUTOPSY CONFIRMED AD PATIENTS AND HEALTHY CONTROLS Alzheimer's & Dementia. 10: P147-P148. DOI: 10.1016/J.Jalz.2014.04.108 |
0.398 |
|
| 2014 |
Cuyvers E, Bettens K, Engelborghs S, Vandenbulcke M, Merlin C, Dillen L, Mattheijssens M, Peeters K, Cras P, Vandenberghe RR, Deyn PD, Zee Jvd, Broeckhoven CV, Sleegers K. Analysis Of Sqstm1 In Patients With Early-Onset Alzheimer'S Disease Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.077 |
0.434 |
|
| 2013 |
Banzhaf-Strathmann J, Claus R, Mücke O, Rentzsch K, van der Zee J, Engelborghs S, De Deyn PP, Cruts M, van Broeckhoven C, Plass C, Edbauer D. Promoter DNA methylation regulates progranulin expression and is altered in FTLD. Acta Neuropathologica Communications. 1: 16. PMID 24252647 DOI: 10.1186/2051-5960-1-16 |
0.349 |
|
| 2013 |
Slaets S, Le Bastard N, Martin JJ, Sleegers K, Van Broeckhoven C, De Deyn PP, Engelborghs S. Cerebrospinal fluid Aβ1-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels. Journal of Alzheimer's Disease : Jad. 36: 759-67. PMID 23666174 DOI: 10.3233/Jad-130107 |
0.454 |
|
| 2013 |
Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. Jama Neurology. 70: 727-35. PMID 23588557 DOI: 10.1001/Jamaneurol.2013.1925 |
0.343 |
|
| 2013 |
Van Bogaert P, Van Grinsven R, Tolson D, Wouters K, Engelborghs S, Van der Mussele S. Effects of SolCos model-based individual reminiscence on older adults with mild to moderate dementia due to Alzheimer disease: a pilot study. Journal of the American Medical Directors Association. 14: 528.e9-13. PMID 23583001 DOI: 10.1016/J.Jamda.2013.01.020 |
0.809 |
|
| 2013 |
Van Cauwenberghe C, Bettens K, Engelborghs S, Vandenbulcke M, Van Dongen J, Vermeulen S, Vandenberghe R, De Deyn PP, Van Broeckhoven C, Sleegers K. Complement receptor 1 coding variant p.Ser1610Thr in Alzheimer's disease and related endophenotypes. Neurobiology of Aging. 34: 2235.e1-6. PMID 23582656 DOI: 10.1016/J.Neurobiolaging.2013.03.008 |
0.389 |
|
| 2013 |
Molinuevo JL, Gispert JD, Dubois B, Heneka MT, Lleo A, Engelborghs S, Pujol J, de Souza LC, Alcolea D, Jessen F, Sarazin M, Lamari F, Balasa M, Antonell A, Rami L. The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study. Journal of Alzheimer's Disease : Jad. 36: 67-77. PMID 23524657 DOI: 10.3233/Jad-130203 |
0.455 |
|
| 2013 |
Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, Kolen KV, Geller F, Sottejeau Y, Harold D, Dourlen P, Grenier-Boley B, Kamatani Y, Delepine B, Demiautte F, Zelenika D, ... ... Engelborghs S, et al. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Molecular Psychiatry. 18: 1225-34. PMID 23399914 DOI: 10.1038/Mp.2013.1 |
0.309 |
|
| 2013 |
Slaets S, Le Bastard N, Theuns J, Sleegers K, Verstraeten A, De Leenheir E, Luyckx J, Martin JJ, Van Broeckhoven C, Engelborghs S. Amyloid pathology influences aβ1-42 cerebrospinal fluid levels in dementia with lewy bodies. Journal of Alzheimer's Disease : Jad. 35: 137-46. PMID 23364139 DOI: 10.3233/Jad-122176 |
0.491 |
|
| 2013 |
Vanderstichele HM, Shaw L, Vandijck M, Jeromin A, Zetterberg H, Blennow K, Teunissen C, Engelborghs S. Alzheimer disease biomarker testing in cerebrospinal fluid: a method to harmonize assay platforms in the absence of an absolute reference standard. Clinical Chemistry. 59: 710-2. PMID 23355631 DOI: 10.1373/Clinchem.2012.201830 |
0.34 |
|
| 2013 |
Cacace R, Van Cauwenberghe C, Bettens K, Gijselinck I, van der Zee J, Engelborghs S, Vandenbulcke M, Van Dongen J, Bäumer V, Dillen L, Mattheijssens M, Peeters K, Cruts M, Vandenberghe R, De Deyn PP, et al. C9orf72 G4C2 repeat expansions in Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging. 34: 1712.e1-7. PMID 23352322 DOI: 10.1016/J.Neurobiolaging.2012.12.019 |
0.484 |
|
| 2013 |
Engelborghs S, Sleegers K, Van der Mussele S, Le Bastard N, Brouwers N, Van Broeckhoven C, De Deyn PP. Brain-specific tryptophan hydroxylase, TPH2, and 5-HTTLPR are associated with frontal lobe symptoms in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 35: 67-73. PMID 23334703 DOI: 10.3233/Jad-101305 |
0.823 |
|
| 2013 |
Van der Mussele S, Bekelaar K, Le Bastard N, Vermeiren Y, Saerens J, Somers N, Mariën P, Goeman J, De Deyn PP, Engelborghs S. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease. International Journal of Geriatric Psychiatry. 28: 947-58. PMID 23255479 DOI: 10.1002/Gps.3909 |
0.833 |
|
| 2013 |
Vermeiren Y, Le Bastard N, Van Hemelrijck A, Drinkenburg WH, Engelborghs S, De Deyn PP. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 488-98. PMID 23159046 DOI: 10.1016/J.Jalz.2012.06.010 |
0.414 |
|
| 2013 |
van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Engelborghs S, Philtjens S, Vandenbulcke M, Sleegers K, Sieben A, Bäumer V, Maes G, Corsmit E, Borroni B, Padovani A, ... ... Engelborghs S, ... ... Engelborghs S, et al. A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Human Mutation. 34: 363-73. PMID 23111906 DOI: 10.1002/Humu.22244 |
0.324 |
|
| 2013 |
Le Bastard N, Aerts L, Sleegers K, Martin JJ, Van Broeckhoven C, De Deyn PP, Engelborghs S. Longitudinal stability of cerebrospinal fluid biomarker levels: fulfilled requirement for pharmacodynamic markers in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 33: 807-22. PMID 23034521 DOI: 10.3233/JAD-2012-110029 |
0.375 |
|
| 2013 |
Le Bastard N, Coart E, Vanderstichele H, Vanmechelen E, Martin JJ, Engelborghs S. Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia. Journal of Alzheimer's Disease : Jad. 33: 117-31. PMID 22936010 DOI: 10.3233/Jad-2012-121246 |
0.497 |
|
| 2013 |
Azermai M, Petrovic M, Engelborghs S, Elseviers MM, Van der Mussele S, Debruyne H, Van Bortel L, Vander Stichele RH. The effects of abrupt antipsychotic discontinuation in cognitively impaired older persons: a pilot study. Aging & Mental Health. 17: 125-32. PMID 22928861 DOI: 10.1080/13607863.2012.717255 |
0.366 |
|
| 2013 |
Van der Mussele S, Le Bastard N, Vermeiren Y, Saerens J, Somers N, Mariën P, Goeman J, De Deyn PP, Engelborghs S. Behavioral symptoms in mild cognitive impairment as compared with Alzheimer's disease and healthy older adults. International Journal of Geriatric Psychiatry. 28: 265-75. PMID 22549770 DOI: 10.1002/Gps.3820 |
0.829 |
|
| 2013 |
Engelborghs S. CSF Biomarkers for Alzheimer Disease Diagnosis: Recent and Future Perspectives Journal of Neurological Disorders. 1. DOI: 10.4172/2329-6895.1000E102 |
0.519 |
|
| 2013 |
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, ... ... Engelborghs S, et al. Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nature Genetics. 45: 712-712. DOI: 10.1038/Ng0613-712A |
0.356 |
|
| 2013 |
Engelborghs S, Stoops E, Brix B, Demeyer L, Jacobs D, Struyfs H, Vanmechelen E. P1-171: A new era of CSF biomarker testing in the field of Alzheimer's disease Alzheimer's & Dementia. 9: P211-P211. DOI: 10.1016/J.Jalz.2013.05.394 |
0.398 |
|
| 2013 |
Vos AD, Jacobs D, Vanmechelen E, Winderickx J, Brande JVd, Engelborghs S, Struyfs H, Blennow K, Zetterberg H. Detection and quantification of novel tau/phospho-tau epitopes in CSF using a multiplex assay approach Alzheimers & Dementia. 9: 332. DOI: 10.1016/J.Jalz.2013.04.185 |
0.309 |
|
| 2012 |
Engelborghs S, Le Bastard N. The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementia. Journal of the Neurological Sciences. 322: 197-9. PMID 22947896 DOI: 10.1016/J.Jns.2012.08.003 |
0.511 |
|
| 2012 |
del Campo M, Mollenhauer B, Bertolotto A, Engelborghs S, Hampel H, Simonsen AH, Kapaki E, Kruse N, Le Bastard N, Lehmann S, Molinuevo JL, Parnetti L, Perret-Liaudet A, Sáez-Valero J, Saka E, et al. Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update. Biomarkers in Medicine. 6: 419-30. PMID 22917144 DOI: 10.2217/Bmm.12.46 |
0.418 |
|
| 2012 |
Engelborghs S, Le Bastard N. The impact of cerebrospinal fluid biomarkers on the diagnosis of Alzheimer's disease. Molecular Diagnosis & Therapy. 16: 135-41. PMID 22646065 DOI: 10.1007/Bf03262201 |
0.511 |
|
| 2012 |
Naudé PJ, Nyakas C, Eiden LE, Ait-Ali D, van der Heide R, Engelborghs S, Luiten PG, De Deyn PP, den Boer JA, Eisel UL. Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2811-23. PMID 22441986 DOI: 10.1096/Fj.11-202457 |
0.352 |
|
| 2012 |
Bettens K, Brouwers N, Engelborghs S, Lambert JC, Rogaeva E, Vandenberghe R, Le Bastard N, Pasquier F, Vermeulen S, Van Dongen J, Mattheijssens M, Peeters K, Mayeux R, St George-Hyslop P, Amouyel P, et al. Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk. Molecular Neurodegeneration. 7: 3. PMID 22248099 DOI: 10.1186/1750-1326-7-3 |
0.358 |
|
| 2012 |
Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S, Engelborghs S, Sieben A, De Jonghe P, Vandenberghe R, Santens P, et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. The Lancet. Neurology. 11: 54-65. PMID 22154785 DOI: 10.1016/S1474-4422(11)70261-7 |
0.316 |
|
| 2012 |
Meeus B, Verstraeten A, Crosiers D, Engelborghs S, Van den Broeck M, Mattheijssens M, Peeters K, Corsmit E, Elinck E, Pickut B, Vandenberghe R, Cras P, De Deyn PP, Van Broeckhoven C, Theuns J. DLB and PDD: a role for mutations in dementia and Parkinson disease genes? Neurobiology of Aging. 33: 629.e5-629.e18. PMID 22118943 DOI: 10.1016/J.Neurobiolaging.2011.10.014 |
0.392 |
|
| 2012 |
Vanderstichele H, Bibl M, Engelborghs S, Le Bastard N, Lewczuk P, Molinuevo JL, Parnetti L, Perret-Liaudet A, Shaw LM, Teunissen C, Wouters D, Blennow K. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 65-73. PMID 22047631 DOI: 10.1016/J.Jalz.2011.07.004 |
0.448 |
|
| 2012 |
Le Bastard N, Engelborghs S. The value of cerebrospinal fluid biomarkers for the differential diagnosis of dementia Neurodegenerative Disease Management. 2: 211-219. DOI: 10.2217/Nmt.12.11 |
0.48 |
|
| 2012 |
Sims R, Hollingworth P, Sweet R, Engelborghs S, Spalletta G, Mayeux R, Kamboh I, Williams J. Follow up of Alzheimer's disease with psychosis genome-wide association studies Alzheimers & Dementia. 8: 676. DOI: 10.1016/J.Jalz.2012.05.1831 |
0.372 |
|
| 2012 |
Bettens K, Cauwenberghe CV, Cuyvers E, Bastard NL, Engelborghs S, Vandenberghe R, Deyn PD, Broeckhoven CV, Sleegers K. Genetic association and interaction of Alzheimer's risk genes CLU, CR1, BIN1, PICALM and MS4A in a Flanders-Belgian cohort Alzheimers & Dementia. 8: 671. DOI: 10.1016/J.Jalz.2012.05.1815 |
0.321 |
|
| 2012 |
Dierckx E, Engelborghs S, Mussele SVd, Deyn PPD, Ponjaert-Kristoffersen I. Are depressive symptoms in mild cognitive impairment patients predictive for conversion to dementia Alzheimers & Dementia. 8: 481. DOI: 10.1016/J.Jalz.2012.05.1302 |
0.42 |
|
| 2011 |
van der Zee J, Van Langenhove T, Kleinberger G, Sleegers K, Engelborghs S, Vandenberghe R, Santens P, Van den Broeck M, Joris G, Brys J, Mattheijssens M, Peeters K, Cras P, De Deyn PP, Cruts M, et al. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain : a Journal of Neurology. 134: 808-15. PMID 21354975 DOI: 10.1093/Brain/Awr007 |
0.339 |
|
| 2011 |
De Witte L, Brouns R, Kavadias D, Engelborghs S, De Deyn PP, Mariën P. Cognitive, affective and behavioural disturbances following vascular thalamic lesions: a review. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 47: 273-319. PMID 21111408 DOI: 10.1016/J.Cortex.2010.09.002 |
0.312 |
|
| 2011 |
Dierckx E, Engelborghs S, De Raedt R, De Deyn PP, D'Haenens E, Verte D, Ponjaert-Kristoffersen I. The 10-word learning task in the differential diagnosis of early Alzheimer's disease and elderly depression: A cross-sectional pilot study. Aging & Mental Health. 15: 113-21. PMID 20924811 DOI: 10.1080/13607863.2010.505228 |
0.4 |
|
| 2011 |
Engelborghs S, Le Bastard N, Feyen B, Goeman J, Martin J, De Deyn P. P2-096: Overdiagnosis of vascular dementia using structural brain imaging in the context of standard clinical diagnostic criteria Alzheimer's & Dementia. 7: S338-S339. DOI: 10.1016/J.Jalz.2011.05.986 |
0.346 |
|
| 2011 |
Slaets S, Le Bastard N, De Leenheir E, Luyckx J, Martin J, De Deyn P, Engelborghs S. P2-069: The CSF Aβ1-40/Aβ1-42 ratio for differential dementia diagnosis Alzheimer's & Dementia. 7: S329-S329. DOI: 10.1016/J.Jalz.2011.05.959 |
0.463 |
|
| 2011 |
Slaets S, Engelborghs S, Le Bastard N, De Deyn P, De Leenheir E, Luyckx J, Martin J. P1-113: Influence of AD pathology on CSF biomarkers in autopsy-confirmed Dementia with Lewy Bodies patients Alzheimer's & Dementia. 7: S146-S146. DOI: 10.1016/J.Jalz.2011.05.392 |
0.49 |
|
| 2011 |
Vermeiren Y, Le Bastard N, Van Hemelrijck A, Drinkenburg W, De Deyn P, Engelborghs S. P4-177: Correlates of cerebrospinal fluid neurotransmitter alterations with behavioral disturbances in dementia Alzheimer's & Dementia. 7: S765-S766. DOI: 10.1016/J.Jalz.2011.05.2200 |
0.42 |
|
| 2011 |
Engelborghs S. PL-04-02: Diagnostic value of CSF biomarkers for (differential) dementia diagnosis Alzheimer's & Dementia. 7: S673-S673. DOI: 10.1016/J.Jalz.2011.05.1940 |
0.376 |
|
| 2011 |
Van der Mussele S, Le Bastard N, Vermeiren Y, Saerens J, Somers N, Marien P, Jordens K, Van Buggenhout M, Goeman J, De Deyn P, Engelborghs S. P3-105: Prognostic value of frontal lobe symptoms in mild cognitive impairment for conversion to Alzheimer's disease Alzheimer's & Dementia. 7: S547-S548. DOI: 10.1016/J.Jalz.2011.05.1545 |
0.487 |
|
| 2011 |
Van der Mussele S, Le Bastard N, Vermeiren Y, Saerens J, Somers N, Marien P, Goeman J, De Deyn P, Engelborghs S. P3-104: Behavioral symptoms in mild cognitive impairment as compared to Alzheimer's disease and healthy elderly Alzheimer's & Dementia. 7: S547-S547. DOI: 10.1016/J.Jalz.2011.05.1544 |
0.519 |
|
| 2011 |
Dierckx E, Carlon M, Engelborghs S, Raedt RD, Deyn PD, Ponjaert-Kristoffersen I. Early detection of MCI: Is the MoCA more sensitive for cognitive decline than the MMSE (a pilot study) Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1511 |
0.344 |
|
| 2010 |
Aries MJ, Le Bastard N, Debruyne H, Van Buggenhout M, Nagels G, De Deyn PP, Engelborghs S. Relation between frontal lobe symptoms and dementia severity within and across diagnostic dementia categories. International Journal of Geriatric Psychiatry. 25: 1186-95. PMID 20957694 DOI: 10.1002/Gps.2481 |
0.455 |
|
| 2010 |
Lambert JC, Sleegers K, González-Pérez A, Ingelsson M, Beecham GW, Hiltunen M, Combarros O, Bullido MJ, Brouwers N, Bettens K, Berr C, Pasquier F, Richard F, Dekosky ST, Hannequin D, ... ... Engelborghs S, et al. The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. Journal of Alzheimer's Disease : Jad. 22: 247-55. PMID 20847397 DOI: 10.3233/Jad-2010-100933 |
0.409 |
|
| 2010 |
De Meyer G, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Archives of Neurology. 67: 949-56. PMID 20697045 DOI: 10.1001/Archneurol.2010.179 |
0.393 |
|
| 2010 |
Brouwers N, Bettens K, Gijselinck I, Engelborghs S, Pickut BA, Van Miegroet H, Montoya AG, Mattheijssens M, Peeters K, De Deyn PP, Cruts M, Sleegers K, Van Broeckhoven C. Contribution of TARDBP to Alzheimer's disease genetic etiology. Journal of Alzheimer's Disease : Jad. 21: 423-30. PMID 20555136 DOI: 10.3233/Jad-2010-100198 |
0.421 |
|
| 2010 |
Chen CC, Engelborghs S, Dewaele S, Le Bastard N, Martin JJ, Vanhooren V, Libert C, De Deyn PP. Altered serum glycomics in Alzheimer disease: a potential blood biomarker? Rejuvenation Research. 13: 439-44. PMID 20426627 DOI: 10.1089/Rej.2009.0992 |
0.471 |
|
| 2010 |
Le Bastard N, Leurs J, Blomme W, De Deyn PP, Engelborghs S. Plasma amyloid-beta forms in Alzheimer's disease and non-Alzheimer's disease patients. Journal of Alzheimer's Disease : Jad. 21: 291-301. PMID 20421698 DOI: 10.3233/Jad-2010-091501 |
0.462 |
|
| 2010 |
Bettens K, Brouwers N, Van Miegroet H, Gil A, Engelborghs S, De Deyn PP, Vandenberghe R, Van Broeckhoven C, Sleegers K. Follow-up study of susceptibility loci for Alzheimer's disease and onset age identified by genome-wide association. Journal of Alzheimer's Disease : Jad. 19: 1169-75. PMID 20308783 DOI: 10.3233/Jad-2010-1310 |
0.433 |
|
| 2010 |
Meeus B, Nuytemans K, Crosiers D, Engelborghs S, Peeters K, Mattheijssens M, Elinck E, Corsmit E, De Deyn PP, Van Broeckhoven C, Theuns J. Comprehensive genetic and mutation analysis of familial dementia with lewy bodies linked to 2q35-q36 Journal of Alzheimer's Disease. 20: 197-205. PMID 20164589 DOI: 10.3233/Jad-2010-1356 |
0.314 |
|
| 2010 |
Le Bastard N, Martin JJ, Vanmechelen E, Vanderstichele H, De Deyn PP, Engelborghs S. Added diagnostic value of CSF biomarkers in differential dementia diagnosis. Neurobiology of Aging. 31: 1867-76. PMID 19150153 DOI: 10.1016/J.Neurobiolaging.2008.10.017 |
0.489 |
|
| 2010 |
Le Bastard N, Bekelaar K, Elseviers M, Van Buggenhout M, Mariën P, Saerens J, Somers N, De Deyn PP, Engelborghs S. P4-009: Characterisation of Depression in Dementia and Mild Cognitive Impairment Alzheimer's & Dementia. 6: e23-e23. DOI: 10.1016/J.Jalz.2010.08.069 |
0.415 |
|
| 2010 |
Bettens K, Brouwers N, Gil A, Miegroet HV, Engelborghs S, Deyn PPD, Vandenberghe R, Sleegers K, Broeckhoven CV. In-depth molecular genetic analysis of CLU in Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.217 |
0.372 |
|
| 2010 |
Le Bastard N, Aerts L, De Deyn PP, Engelborghs S. P3-262: Longitudinal stability of CSF biomarker levels Alzheimer's & Dementia. 6: S528-S528. DOI: 10.1016/J.Jalz.2010.05.1762 |
0.303 |
|
| 2010 |
Le Bastard N, De Deyn PP, Engelborghs S. P3-231: Plasma beta-amyloid levels: Diagnostic markers for dementia diagnosis? Alzheimer's & Dementia. 6: S519-S519. DOI: 10.1016/J.Jalz.2010.05.1730 |
0.362 |
|
| 2010 |
Dierckx E, Engelborghs S, Raedt RD, Buggenhout MV, Deyn PPD, Ponjaert-Kristoffersen I. Predicting conversion to Alzheimer's disease in Mild Cognitive Impairment: cued recall versus free delayed recall Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1197 |
0.399 |
|
| 2009 |
De Smet HJ, Baillieux H, Wackenier P, De Praeter M, Engelborghs S, Paquier PF, De Deyn PP, Mariën P. Long-term cognitive deficits following posterior fossa tumor resection: a neuropsychological and functional neuroimaging follow-up study. Neuropsychology. 23: 694-704. PMID 19899828 DOI: 10.1037/A0016106 |
0.339 |
|
| 2009 |
Koopman K, Le Bastard N, Martin JJ, Nagels G, De Deyn PP, Engelborghs S. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P). Neurochemistry International. 55: 214-8. PMID 19524111 DOI: 10.1016/J.Neuint.2009.02.017 |
0.5 |
|
| 2009 |
Bettens K, Brouwers N, Engelborghs S, Van Miegroet H, De Deyn PP, Theuns J, Sleegers K, Van Broeckhoven C. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. Human Mutation. 30: 1207-13. PMID 19462468 DOI: 10.1002/Humu.21027 |
0.343 |
|
| 2009 |
Sleegers K, Brouwers N, Bettens K, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population. Human Mutation. 30: E570-4. PMID 19191332 DOI: 10.1002/Humu.20990 |
0.412 |
|
| 2009 |
Debruyne H, Van Buggenhout M, Le Bastard N, Aries M, Audenaert K, De Deyn PP, Engelborghs S. Is the geriatric depression scale a reliable screening tool for depressive symptoms in elderly patients with cognitive impairment? International Journal of Geriatric Psychiatry. 24: 556-62. PMID 19132643 DOI: 10.1002/Gps.2154 |
0.346 |
|
| 2009 |
Sleegers K, Bettens K, Brouwers N, Engelborghs S, van Miegroet H, De Deyn PP, Van Broeckhoven C. Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia. Human Mutation. 30: E338-44. PMID 18853460 DOI: 10.1002/Humu.20909 |
0.415 |
|
| 2009 |
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, ... ... Engelborghs S, et al. Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nature Genetics. 41: 1156-1156. DOI: 10.1038/Ng1009-1156D |
0.356 |
|
| 2009 |
Bettens K, Brouwers N, Van Miegroet H, Engelborghs S, De Deyn P, Theuns J, Sleegers K, Van Broeckhoven C. O4-01-02: APP and BACE1 miRNA genetic variability in risk for Alzheimer's disease Alzheimer's & Dementia. 5: P149-P149. DOI: 10.1016/J.Jalz.2009.05.514 |
0.308 |
|
| 2008 |
Dierckx E, Engelborghs S, De Raedt R, Van Buggenhout M, De Deyn PP, Verleye G, Verte D, Ponjaert-Kristoffersen I. Differentiation between dementia and depression among older persons: can the difference between actual and premorbid intelligence be useful? Journal of Geriatric Psychiatry and Neurology. 21: 242-9. PMID 19017781 DOI: 10.1177/0891988708324938 |
0.387 |
|
| 2008 |
De Witte L, Engelborghs S, Verhoeven J, De Deyn PP, Mariën P. Disrupted auto-activation, dysexecutive and confabulating syndrome following bilateral thalamic and right putaminal stroke. Behavioural Neurology. 19: 145-51. PMID 18641434 DOI: 10.1155/2008/693671 |
0.301 |
|
| 2008 |
Brouwers N, Sleegers K, Engelborghs S, Maurer-Stroh S, Gijselinck I, van der Zee J, Pickut BA, Van den Broeck M, Mattheijssens M, Peeters K, Schymkowitz J, Rousseau F, Martin JJ, Cruts M, De Deyn PP, et al. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology. 71: 656-64. PMID 18565828 DOI: 10.1212/01.Wnl.0000319688.89790.7A |
0.317 |
|
| 2008 |
Bettens K, Brouwers N, Engelborghs S, De Deyn PP, Van Broeckhoven C, Sleegers K. SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population. Human Mutation. 29: 769-70. PMID 18407551 DOI: 10.1002/Humu.20725 |
0.372 |
|
| 2008 |
Mariën P, Baillieux H, De Smet HJ, Engelborghs S, Wilssens I, Paquier P, De Deyn PP. Cognitive, linguistic and affective disturbances following a right superior cerebellar artery infarction: a case study. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 45: 527-36. PMID 18396269 DOI: 10.1016/J.Cortex.2007.12.010 |
0.326 |
|
| 2008 |
Bettens K, Brouwers N, Engelborghs S, De Pooter T, De Deyn PP, Sleegers K, Van Broeckhoven C. DNMBP is genetically associated with Alzheimer dementia in the Belgian population. Neurobiology of Aging. 30: 2000-9. PMID 18359537 DOI: 10.1016/J.Neurobiolaging.2008.02.003 |
0.356 |
|
| 2008 |
Engelborghs S, Vloeberghs E, Le Bastard N, Van Buggenhout M, Mariën P, Somers N, Nagels G, Pickut BA, De Deyn PP. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia. Neurochemistry International. 52: 1052-60. PMID 18093695 DOI: 10.1016/J.Neuint.2007.10.018 |
0.788 |
|
| 2008 |
Engelborghs S, De Vreese K, Van de Casteele T, Vanderstichele H, Van Everbroeck B, Cras P, Martin JJ, Vanmechelen E, De Deyn PP. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiology of Aging. 29: 1143-59. PMID 17428581 DOI: 10.1016/j.neurobiolaging.2007.02.016 |
0.366 |
|
| 2008 |
Le Bastard N, De Deyn PP, Engelborghs S. P1-349: Plasma amyloid isoforms allow screening for mild cognitive impairment among healthy elderly Alzheimer's & Dementia. 4: T321-T321. DOI: 10.1016/J.Jalz.2008.05.930 |
0.381 |
|
| 2008 |
Engelborghs S, Le Bastard N, De Deyn PP. P1-344: Plasma amyloid isoforms in non-Alzheimer's disease patients Alzheimer's & Dementia. 4: T320-T320. DOI: 10.1016/J.Jalz.2008.05.925 |
0.42 |
|
| 2008 |
Le Bastard N, Van Buggenhout M, De Deyn PP, Engelborghs S. P1-166: CSF biomarkers predict conversion to dementia in mild cognitive impairment Alzheimer's & Dementia. 4: T256-T257. DOI: 10.1016/J.Jalz.2008.05.754 |
0.445 |
|
| 2008 |
Engelborghs S, Aries M, Le Bastard N, Debruyne H, Van Buggenhout M, Nagels G, De Deyn PP. O3-06-05: Progression of frontal lobe symptoms in frontotemporal dementia and dementia with Lewy bodies as compared with Alzheimer's disease Alzheimer's & Dementia. 4: T171-T172. DOI: 10.1016/J.Jalz.2008.05.454 |
0.494 |
|
| 2008 |
Le Bastard N, Van Buggenhout M, Debruyne H, Aries M, De Deyn PP, Engelborghs S. O2-07-02: Is the geriatric depression scale a reliable screening tool for depressive symptoms in elderly patients with cognitive impairment? Alzheimer's & Dementia. 4: T146-T146. DOI: 10.1016/J.Jalz.2008.05.359 |
0.456 |
|
| 2008 |
Engelborghs S, Le Bastard N, Vloeberghs E, Van Buggenhout M, Nagels G, Pickut BA, De Deyn PP. P3-392: The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia Alzheimer's & Dementia. 4: T636-T636. DOI: 10.1016/J.Jalz.2008.05.1962 |
0.773 |
|
| 2008 |
Sleegers K, Bettens K, Engelborghs S, Brouwers N, van Miegroet H, De Deyn PP, Van Broeckhoven C. P3-266: GAB2 and risk for Alzheimer's dementia in a Belgian population Alzheimer's & Dementia. 4: T600-T600. DOI: 10.1016/J.Jalz.2008.05.1834 |
0.434 |
|
| 2008 |
Brouwers N, Sleegers K, Engelborghs S, Maurer-Stroh S, Gijselinck I, van der Zee J, Pickut B, Van den Broeck M, Mattheijssens M, Peeters K, Schymkowitz J, Rousseau F, Martin J, Cruts M, De Deyn PP, et al. P3-206: Genetic variability at the progranulin locus contributes to risk for Alzheimer's disease Alzheimer's & Dementia. 4: T581-T581. DOI: 10.1016/J.Jalz.2008.05.1773 |
0.308 |
|
| 2008 |
Bettens K, Brouwers N, Engelborghs S, De Deyn P, Van Broeckhoven C, Sleegers K. P3-202: The neuronal sorting receptor SORL1 is genetically associated with increased risk for late-onset Alzheimer's disease in the Belgian population Alzheimer's & Dementia. 4: T579-T580. DOI: 10.1016/J.Jalz.2008.05.1769 |
0.349 |
|
| 2008 |
Le Bastard N, Martin J, De Deyn PP, Engelborghs S. P3-080: Value of CSF biomarkers in differential dementia diagnosis Alzheimer's & Dementia. 4: T541-T541. DOI: 10.1016/J.Jalz.2008.05.1644 |
0.404 |
|
| 2008 |
Engelborghs S, Koopman K, Le Bastard N, Martin J, De Deyn PP. P3-068: Improved discrimination of Alzheimer's disease from other dementias using cerebrospinal fluid P-tau181P Alzheimer's & Dementia. 4: T537-T537. DOI: 10.1016/J.Jalz.2008.05.1632 |
0.458 |
|
| 2007 |
Mariën P, Brouns R, Engelborghs S, Wackenier P, Verhoeven J, Ceulemans B, De Deyn PP. Cerebellar cognitive affective syndrome without global mental retardation in two relatives with Gillespie syndrome. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 44: 54-67. PMID 18387531 DOI: 10.1016/J.Cortex.2005.12.001 |
0.363 |
|
| 2007 |
Brouwers N, Nuytemans K, van der Zee J, Gijselinck I, Engelborghs S, Theuns J, Kumar-Singh S, Pickut BA, Pals P, Dermaut B, Bogaerts V, De Pooter T, Serneels S, Van den Broeck M, Cuijt I, et al. Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Archives of Neurology. 64: 1436-46. PMID 17923627 DOI: 10.1001/Archneur.64.10.1436 |
0.372 |
|
| 2007 |
Le Bastard N, Van Buggenhout M, De Leenheir E, Martin JJ, De Deyn PP, Engelborghs S. LOW specificity limits the use of the cerebrospinal fluid AB1-42/P-TAU181P ratio to discriminate alzheimer's disease from vascular dementia. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 62: 923-4; author reply . PMID 17702886 DOI: 10.1093/Gerona/62.8.923 |
0.461 |
|
| 2007 |
Engelborghs S, Sleegers K, Cras P, Brouwers N, Serneels S, De Leenheir E, Martin JJ, Vanmechelen E, Van Broeckhoven C, De Deyn PP. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease. Brain : a Journal of Neurology. 130: 2320-6. PMID 17586559 DOI: 10.1093/Brain/Awm136 |
0.409 |
|
| 2007 |
Wollmer MA, Sleegers K, Ingelsson M, Zekanowski C, Brouwers N, Maruszak A, Brunner F, Huynh KD, Kilander L, Brundin RM, Hedlund M, Giedraitis V, Glaser A, Engelborghs S, De Deyn PP, et al. Association study of cholesterol-related genes in Alzheimer's disease. Neurogenetics. 8: 179-88. PMID 17387528 DOI: 10.1007/S10048-007-0087-Z |
0.424 |
|
| 2007 |
Nagels G, Engelborghs S, Vloeberghs E, Lemmens W, Pickut BA, De Deyn PP. Correlation between actigraphy and nurses' observation of activity in dementia. International Journal of Geriatric Psychiatry. 22: 84-6. PMID 17171751 DOI: 10.1002/Gps.1647 |
0.722 |
|
| 2006 |
Brouwers N, Sleegers K, Engelborghs S, Bogaerts V, Serneels S, Kamali K, Corsmit E, De Leenheir E, Martin JJ, De Deyn PP, Van Broeckhoven C, Theuns J. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain : a Journal of Neurology. 129: 2984-91. PMID 16931535 DOI: 10.1093/Brain/Awl212 |
0.368 |
|
| 2006 |
Engelborghs S, Maertens K, Mariën P, Vloeberghs E, Somers N, Nagels G, De Deyn PP. Behavioural and neuropsychological correlates of frontal lobe features in dementia. Psychological Medicine. 36: 1173-82. PMID 16700962 DOI: 10.1017/S003329170600777X |
0.767 |
|
| 2006 |
Nagels G, Engelborghs S, Vloeberghs E, Van Dam D, Pickut BA, De Deyn PP. Actigraphic measurement of agitated behaviour in dementia. International Journal of Geriatric Psychiatry. 21: 388-93. PMID 16534768 DOI: 10.1002/Gps.1483 |
0.752 |
|
| 2006 |
van der Zee J, Rademakers R, Engelborghs S, Gijselinck I, Bogaerts V, Vandenberghe R, Santens P, Caekebeke J, De Pooter T, Peeters K, Lübke U, Van den Broeck M, Martin JJ, Cruts M, De Deyn PP, et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain : a Journal of Neurology. 129: 841-52. PMID 16495329 DOI: 10.1093/Brain/Awl029 |
0.303 |
|
| 2006 |
Engelborghs S, Maertens K, Vloeberghs E, Aerts T, Somers N, Mariën P, De Deyn PP. Neuropsychological and behavioural correlates of CSF biomarkers in dementia. Neurochemistry International. 48: 286-95. PMID 16434124 DOI: 10.1016/J.Neuint.2005.11.002 |
0.782 |
|
| 2006 |
Engelborghs S, Dermaut B, Mariën P, Symons A, Vloeberghs E, Maertens K, Somers N, Goeman J, Rademakers R, Van den Broeck M, Pickut B, Cruts M, Van Broeckhoven C, De Deyn PP. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Neurobiology of Aging. 27: 285-92. PMID 16399213 DOI: 10.1016/J.Neurobiolaging.2005.02.005 |
0.808 |
|
| 2006 |
Brouwers N, Sleegers K, Engelborghs S, Bogaerts V, van Duijn CM, De Deyn PP, Van Broeckhoven C, Dermaut B. The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer's disease with onset before 70 years. Neuroscience Letters. 392: 72-4. PMID 16214290 DOI: 10.1016/J.Neulet.2005.08.064 |
0.436 |
|
| 2006 |
Vos SJ, Bos I, Verhey FR, Engelborghs S, Lleó A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Frisoni GB, Blin O, Richardson J, Bordet R, Scheltens P, Ramakers IH, et al. P2-270: INCREASED CSF AMYLOID-β 1-38 AND 1-40 CONCENTRATIONS IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT WITH TAU BUT WITHOUT AMYLOID PATHOPHYSIOLOGY Alzheimer's & Dementia. 14: P780-P781. DOI: 10.1016/J.Jalz.2018.06.959 |
0.422 |
|
| 2006 |
ten Kate M, Redolfi A, Peira E, Bos I, Vos SJ, Scheltens P, Engelborghs S, Frisoni GB, Blin O, Richardson J, Bordet R, Wallin A, Molinuevo JL, Tsolaki M, Verhey FR, et al. F1-02-03: MRI PREDICTORS OF AMYLOID PATHOLOGY: RESULTS FROM THE EMIF-AD BIOMARKER DISCOVERY STUDY Alzheimer's & Dementia. 14: P202-P204. DOI: 10.1016/J.Jalz.2018.06.2309 |
0.388 |
|
| 2006 |
Westwood S, Baird AL, Anand SN, Shi L, Nevado-Holgado AJ, Kormilitzin A, Hye A, Ashton NJ, Morgan A, Touchard S, Morgan P, Bos I, Vos SJ, Vandenberghe R, Scheltens P, ... Engelborghs S, et al. F1-02-02: DISCOVERY, REPLICATION AND EXTENSION STUDY OF PLASMA PROTEOMIC BIOMARKERS RELATING TO BRAIN AMYLOID BURDEN AND ALZHEIMER'S DISEASE PROGRESSION Alzheimer's & Dementia. 14: P201-P202. DOI: 10.1016/J.Jalz.2018.06.2308 |
0.381 |
|
| 2006 |
Ingala S, ten Kate M, Redolfi A, Wottschel V, Peira E, Bos I, Vos SJ, Scheltens P, Engelborghs S, Frisoni GB, Blin O, Richardson J, Bordet R, Wallin A, Molinuevo JL, et al. P2-458: PREDICTING COGNITIVE DECLINE THROUGH STRUCTURAL MRI BIOMARKERS: RESULTS FROM THE EMIF-AD BIOMARKER DISCOVERY STUDY Alzheimer's & Dementia. 14: P895-P896. DOI: 10.1016/J.Jalz.2018.06.1151 |
0.427 |
|
| 2006 |
Engelborghs S, Mariën P, Vloeberghs E, Somers N, Nagels G, De Deyn PP. P1-425: Behavioral and neuropsychological correlates of frontal lobe features in dementia Alzheimer's & Dementia. 2: S222-S222. DOI: 10.1016/J.Jalz.2006.05.804 |
0.767 |
|
| 2006 |
Engelborghs S, De Vreese K, Van de Casteele T, Vanderstichele H, Van Everbroeck B, Cras P, Martin J, Vanmechelen E, De Deyn PP. O3-01-06: Diagnostic performance of a CSF-biomarker panel compared to clinical diagnosis in 100 autopsy-confirmed dementia cases Alzheimer's & Dementia. 2: S52-S53. DOI: 10.1016/J.Jalz.2006.05.192 |
0.362 |
|
| 2006 |
Engelborghs S, Nagels G, Vloeberghs E, Pickut BA, De Deyn PP. P4-176: Actigraphic measurement of agitated behavior in Dementia Alzheimer's & Dementia. 2: S568-S568. DOI: 10.1016/J.Jalz.2006.05.1915 |
0.763 |
|
| 2006 |
Rademakers R, Sleegers K, Pals P, Nuytemans K, Lohmann E, Durr A, Engelborghs S, Pooter Td, Broeck MVd, Pickut B, Cruts M, Deyn PD, Farrer M, Brice A, Broeckhoven CV. P3-159: MAPT H1 subhaplotyping in european PD association samples implicates tau splicing in early-onset parkinson’s disease susceptibility Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1427 |
0.31 |
|
| 2006 |
Bogaerts V, De Graeve S, Engelborghs S, van der Zee J, Peeters K, Stolz F, Van Dijck P, Theuns J, De Deyn PP, Thevelein J, Van Broeckhoven C. P3-158: A novel locus for autosomal dominant dementia with Lewy bodies on chromosome 2Q35-36 Alzheimer's & Dementia. 2: S420-S420. DOI: 10.1016/J.Jalz.2006.05.1426 |
0.301 |
|
| 2005 |
Engelborghs S, Maertens K, Nagels G, Vloeberghs E, Mariën P, Symons A, Ketels V, Estercam S, Somers N, De Deyn PP. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study. International Journal of Geriatric Psychiatry. 20: 1028-37. PMID 16250064 DOI: 10.1002/Gps.1395 |
0.765 |
|
| 2005 |
De Witte L, Wilssens I, Engelborghs S, De Deyn PP, Mariën P. Impairment of syntax and lexical semantics in a patient with bilateral paramedian thalamic infarction. Brain and Language. 96: 69-77. PMID 16226805 DOI: 10.1016/J.Bandl.2005.08.011 |
0.31 |
|
| 2005 |
Van Dam D, Marescau B, Engelborghs S, Cremers T, Mulder J, Staufenbiel M, De Deyn PP. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Neurochemistry International. 46: 409-22. PMID 15737439 DOI: 10.1016/J.Neuint.2004.11.005 |
0.349 |
|
| 2005 |
De Deyn PP, Engelborghs S, Saerens J, Goeman J, Mariën P, Maertens K, Nagels G, Martin JJ, Pickut BA. The Middelheim Frontality Score: a behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease. International Journal of Geriatric Psychiatry. 20: 70-9. PMID 15578673 DOI: 10.1002/Gps.1249 |
0.503 |
|
| 2004 |
Vloeberghs E, Van Dam D, Engelborghs S, Nagels G, Staufenbiel M, De Deyn PP. Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances. The European Journal of Neuroscience. 20: 2757-66. PMID 15548219 DOI: 10.1111/J.1460-9568.2004.03755.X |
0.747 |
|
| 2004 |
Engelborghs S, Holmes C, McCulley M, De Deyn PP. 5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease International Journal of Geriatric Psychiatry. 19: 1108-1109. PMID 15497194 DOI: 10.1002/Gps.1179 |
0.332 |
|
| 2004 |
Engelborghs S, Vloeberghs E, Maertens K, Mariën P, Somers N, Symons A, Clement F, Ketels V, Saerens J, Goeman J, Pickut BA, Vandevivere J, De Deyn PP. Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia. International Journal of Geriatric Psychiatry. 19: 365-70. PMID 15065230 DOI: 10.1002/Gps.1092 |
0.786 |
|
| 2004 |
Engelborghs S, Holmes C, McCulley M, De Deyn PP. P4-086 5-HT2A receptor polymorphism may modulate antipsychotic treatment response in Alzheimer's disease Neurobiology of Aging. 25: S498-S499. DOI: 10.1016/S0197-4580(04)81644-0 |
0.351 |
|
| 2004 |
Engelborghs S, Dermaut B, Mariën P, Symons A, Vloeberghs E, Maertens K, Somers N, Goeman J, Rademakers R, Van Den Broeck M, Pickut BA, Cruts M, Van Broeckhoven C, De Deyn PP. P4-033 Dose dependent effect of APOE ε4 on behavioral symptoms in frontal lobe dementia patients Neurobiology of Aging. 25: S482. DOI: 10.1016/S0197-4580(04)81591-4 |
0.772 |
|
| 2004 |
De Deyn PP, Engelborghs S, Saerens J, Goeman J, Mariën P, Maertens K, Nagels G, Pickut BA. P3-352 The middelheim frontality score: a behavioral assessment scale that discriminates frontotemporal dementia from Alzheimer's disease Neurobiology of Aging. 25: S455. DOI: 10.1016/S0197-4580(04)81501-X |
0.474 |
|
| 2004 |
Engelborghs S, Maertens K, Vloeberghs E, Mariën P, Symons A, Ketels V, Somers N, Nagels G, Marescau B, De Deyn PP. P3-037 CSF dopac levels predict aggressive and agitated behavior in FTD patients Neurobiology of Aging. 25: S362. DOI: 10.1016/S0197-4580(04)81191-6 |
0.735 |
|
| 2004 |
Engelborghs S, Maertens K, Vloeberghs E, Mariën P, Symons A, Ketels V, Somers N, Nagels G, De Deyn PP. P1-052 A prospective, longitudinal Belgian study on behavioral and psychological signs and symptoms of dementia Neurobiology of Aging. 25: S109. DOI: 10.1016/S0197-4580(04)80366-X |
0.774 |
|
| 2004 |
Dermaut B, Kumar-Singh S, Engelborghs S, Theuns J, Rademakers R, Peeters K, Claes S, Cruts M, Martin J, De Deyn P, Van Broeckhoven C. O3-05-01 A novel presenilin 1 mutation (gly183val) is associated with pick's disease in the absence of β-amyloid plaques Neurobiology of Aging. 25: S61. DOI: 10.1016/S0197-4580(04)80206-9 |
0.318 |
|
| 2003 |
Engelborghs S, Dermaut B, Goeman J, Saerens J, Mariën P, Pickut BA, Van den Broeck M, Serneels S, Cruts M, Van Broeckhoven C, De Deyn PP. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 1148-51. PMID 12876259 DOI: 10.1136/Jmg.40.11.814 |
0.503 |
|
| 2001 |
Engelborghs S, De Deyn PP. Biological and genetic markers of sporadic Alzheimer's disease. Acta Medica Okayama. 55: 55-63. PMID 11332200 DOI: 10.18926/AMO/32010 |
0.345 |
|
| 1999 |
Engelborghs S, De Brabander M, De Crée J, D'Hooge R, Geerts H, Verhaegen H, De Deyn PP. Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type. Neurochemistry International. 34: 523-30. PMID 10402228 DOI: 10.1016/S0197-0186(99)00031-5 |
0.306 |
|
| 1999 |
De Deyn PP, Goeman J, Engelborghs S, Hauben U, D'Hooge R, Baro F, Pickut BA. From neuronal and vascular impairment to dementia. Pharmacopsychiatry. 32: 17-24. PMID 10338104 DOI: 10.1055/S-2007-979232 |
0.38 |
|
| Show low-probability matches. |